The Phospholipase C Signalling System: Study of the role of the G₀ protein and identification of a novel variant of Phospholipase C β4 by De Filippis, Lidia
Open Research Online
The Open University’s repository of research publications
and other research outputs
The Phospholipase C Signalling System: Study of the
role of the G protein and identification of a novel
variant of Phospholipase C 4
Thesis
How to cite:
De Filippis, Lidia (2003). The Phospholipase C Signalling System: Study of the role of the G protein and
identification of a novel variant of Phospholipase C 4. PhD thesis. The Open University.
For guidance on citations see FAQs.
c© 2003 Lidia De Filippis
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
Lidia De Filippis
THE FHOSPHOLIPASE C SIGNALLING
SYSTEM
Study of the role of the Go protein and 
identification of a novel variant of Phospholipase C
(34
Thesis submitted in partial fulfilment of the requirements of the 
Open University for the Degree of doctor of Philosophy in 
Molecular and Cellular Biology
July 2000
DIBIT
Department of Biological and Technological 
Research -  Milan, Italy
ProQuest Number: C813309
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest C813309
Published by ProQuest LLO (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
CONTENTS
DECLARATION p. 5
ABSTRACT p. 6
ABBREVIATIONS P.8
INTRODUCTION p 12
Cell signalling p. 13
G proteins p .l6
G protein a  subunits p.20
Otto subunit p.27
Gprotein Py subunits p.37
Phosphoinositide hydrolysis p.40
Phospholipase C p.41
PLC Y p.46
PLCS p.48
PLC E p.50
PLCP p.50
PLC pi p.51
PLC p2 p.52
PLC P3 p.53
PLC p4 p.53
NorpA p.60
Mechanisms of regulation of PLC P by G protein subunits p.63
Specific background p.70
RESULTS p.71
Regulation of polyphosphoinositide hydrolysis by Ga© protein in Ltk 
fibroblasts p.72
Identification of a new variant of PLC P4 p.94
DISCUSSION p.120
Effect of G tto on polyphosphoinositide hydrolysis p. 121
The Pic P4c enzyme p. 124
MATERIALS AND METHODS p. 132
Plasmid DNAs p.l33
Stable transfection of Ltk cells p. 133
Plasmid DNA preparation p. 134
Transient transfection of COS? cells p. 135
Measurement of inositol phosphate (IP) accumulation p.l36
Measurement of cAMP p. 137
Reverse transcription PCR analysis p. 13 8
Cloning of PLC P4a and PLC P4c p. 140
Analysis of protein expression p. 142
REFERENCES p. 148
DECLARATION
This thesis has been written by myself and has not been used in any other 
previous application for a degree.
The work on Ltk" clones presented in the thesis has been mainly performed by 
Micaela Grandolfo with my help. The isolation of Pic P4 c cDNA from a rat 
brain library and the reconstmction of the full-length sequences of Pic p4 a 
and Pic P4 c have been performed by Barbara Marinelli. All other results 
were obtained by myself. Part of the data contained in this thesis has been 
presented at ECHO 1999, Bologna, Italy (L. De Filippis, B. Marinelli, C. 
Muca and L. Vallar; Identification and characterization of an ubiquitously 
expressed variant of phopsholipase C p4; Abstract A65). All sources of 
information are acknowledged by means of reference.
ABSTRACT
The thesis focuses on the properties and regulation of phospholipase C P 
(PLC P). Studies concerning the effect of Gao subunit on PLC activity 
revealed that mutationally activated Gtto inhibits PLC activity in mouse Ltk" 
clones. The observed effect seemed to be specific of Gtto, as either wild-type 
Gao or the wild-type and mutationally activated Ga^ subunits were not able 
to affect receptor-mediated activation of PLC. Known second messengers as 
Ca^ "*" and cAMP were not involved in this inhibitory process since they were 
not able to mimic or prevent the Gao effect on PLC. Transient transfection 
experiments in C0S7 cells did not riproduce the same results; therefore, either 
a direct or an indirect mechanism of PLC activity regulation by Gao remain 
feasible hypothesis. The thesis also presents results concerning the 
identification of a novel C-terminal variant of PLC P4 (PLC P4c), that has a 
37-nucleotide insertion which results in replacement of 22 aminoacid residues 
at the carboxyl terminal tail of PLC p4a with 41 unique residues. RT-PCR 
and Western Blot experiments did show that, in contrast with the known 
enzyme (PLC p4a) detectable only in brain, PLC p4c is present in several 
tissues and cell lines. Expression of full-length cDNAs in C0S7 cells 
revealed that the two forms of PLC |3 are associated with the particulate 
fraction and equally responsive to G protein subunits. However, the different
carboxyl terminal tails of PLC P4 isoforms may allow for differential 
targeting and subcellular localization, contributing to regulation of PLC P4 - 
mediated specific pathways. Even the presence of a PDZ domain binding 
sequence in PLC P4a but not in PLC p4c suggests functional differences 
between the two variants.
ABBREVIATIONS
AC= adenylate cyclase
ACPD= 1 -amino-1,3 -cyclopentanedicarboxylic acid
ADP=adenosine diphosphate
AR=adrenergic receptor
ATP= adenosine triphosphate
PArk= P adrenergic receptor kinase
bp= base pairs
BCA= bicinchonic acid
BSA= bovine serum albumine
Btk= Bruton’s tyrosine kinase
cAMP= cyclic adenosine monophosphate
Cch= carbachol
cDNA= complementary DNA
CHO= Chinese Hamster Ovary (cells)
Csk= C-terminal src kinase 
CTX= Cholera toxin
DMEM= Dulbecco’s modified Eagle’s medium 
DNA= desossiribonucleic acid 
ECL= enhanced chemioluminescence 
EGF=epidermal growth factor 
ERK= extracellular signal-regulated kinase
FGF= fibroblast growth factor 
g= gravity
GAP=GTPase activating protein 
GEF= guanine nucleotide exchange factor 
GH= growth hormon
G1RK= G protein-coupled inwardly rectifying channel
GOA= C.elegans Go oc subunit
GDP= guanosine diphosphate
GPCR= G protein coupled receptor
Grb=growth factor receptor binding protein
GTP= guanosine triphosphate
HL60= herytroleukemia (cell line)
1NAD= inactivation no-after potential
1P= inositol phosphate
1RS= insulin receptor substrate
KLH= keyhole limpet hemocyanin
LPA= lysophosphatidic acid
LT= leukotrien
LTD= long term depression
mAChR= muscarinic acetylcholine receptor
MAPK= mitogen-activated protein kinase
mGluR= metabotropic glutamate receptor
MCPP= l-(3-clorophenyl) piperazine 
NGF= nerve growth factor 
NORPA= no receptor potential A 
PAF= platelet-activated factor 
PG12= pheochromocitoma 12(cell line)
PCR= polymerase chain reaction 
PDGF= platelet derived growth factor
PDZ= post-synaptic density 95, disc-large and zonulin-1 protein (domain) 
PGE= prostaglandin E 
PH=pleckstrin homologous (domain)
PI3= phosphatydilinositol-3 phosphate
PI4K= phosphatydilinositol-4 phosphate kinase
PIP2= phosphatydil-inositol 4,5 bisphosphate
PKA= protein kinase A
PKC= protein kinase C
PLA2= phospholipase A2
PLC= phospholipase C
PLD= phospholipase D
PMA= phorbol myristate acetate
PTX= pertussis toxin
Raf= ras activating factor
RGS= regulator of G protein signaling
RNA= ribonucleic acid
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RT= reverse transcriptase
SDS= sodium dodecyl sulphate
SE= standard error
Shc= src homolog and collagen
Stat3= signal transducer and activator of transcription
SV40= Simian Virus 40
TG= transglutaminase
TRH= thyroid releasing hormon
TRP= transient receptor potential (channel)
TSH= thyroid stimulating hormon 
TXA= thromboxane 
UTR= untranslated region
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INTRODUCTION
12
CELL SIGNALLING
Each cell in a multicellular animal is programmed during development to 
respond to a specific set of signals that act in various combinations to 
regulate its behavior, beginning with life or death, with proliferation or 
quiescence. Intercellular signals, interpreted by complex machinery in the 
responding cell, allow each cell to determine its position and specialized role 
in the body and ensure, for example, that each cell divides only when its 
neighbors dictate that it should do so. The importance of such “social 
controls” on cell division becomes apparent when the controls fail, resulting 
in cancer, which often kills the multicellular organism.
An animal cell contains an elaborate network of proteins that enables the cell 
to respond to signals from other cells. The system includes cell-surface and 
intracellular receptor proteins, protein kinases, protein phosphatases, GTP- 
binding proteins, and the many intracellular proteins with which these 
signalling proteins interact.
Mechanisms enabling one cell to influence the behavior of another almost 
certainly existed in the world of unicellular organisms long before 
multicellular organisms appeared on earth. Evidence comes from studies of 
some present-day unicellular eucaryotes such as yeasts. Although these cells 
normally lead independent lives, they can communicate and influence one 
another’s proliferation in preparation for sexual mating (Marsh et al., 1991).
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In the budding yeast Saccharomyces cerevisiae, for example, when a haploid 
individual is ready to mate, it secretes a peptide mating factor that signals 
cells of opposite mating types to stop proliferating and prepare to conjugate; 
the subsequent fusion of two haploid cells of the opposite mating types 
produces a diploid cell, which can then undergo meiosis and sporulate to 
generate haploid cells with new assortments of genes. Studies of yeast 
mutants that are unable to mate have identified many proteins that are 
required in the signalling process. These proteins form a signalling network 
that includes cell-surface receptors, GTP-binding proteins, and protein 
kinases, each of which has close relatives among the proteins involved in 
signalling in animal cells. Through gene duplication and divergence, 
however, the signalling systems in animals have become much more 
elaborate than those in yeasts.
Whereas yeast cells communicate with one another for mating by secreting 
several kinds of small peptides, cells in higher organisms communicate by 
means of hundreds of signalling molecules, including proteins, small 
peptides, amino acids, nucleotides, steroids, retinoids, fatty acid derivatives, 
and even dissolved gases such as nitric oxide and carbon monoxide. Most of 
these signalling molecules are secreted fi*om the signalling cell by exocytosis. 
Others are released by diffusion through the plasma membrane, while some 
remain tightly bound to the cell surface and influence only cells that contact 
the signalling cell.
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Regardless of the nature of the signal, the target cell responds by means of a 
specific protein called a receptor. It specifically binds the signalling molecule 
and initiates a response in the target cell. Many of the extracellular signalling 
molecules act at very low concentrations, and the receptors that recognize 
them usually bind them with high affinity. In most cases the receptors are 
transmembrane proteins on the target-cell surface. When they bind an 
extracellular signalling molecule (a ligand), they become activated so as to 
generate a cascade of intracellular signals that alter the behavior of the cell. 
In some cases, however, the receptors are inside the target cell and the 
signalling ligand has to enter the cell to activate them: these signalling 
molecules therefore must be sufficiently small and hydrophobic to diffuse 
across the plasma membrane.
There are three main families of cell-surface receptors, each o f which 
transduces extracellular signals in a different way. lon-channel receptors are 
transmitter-gated ion channels, involved in rapid synaptic signalling between 
electrically excitable cells. This type of signalling is mediated by a small 
number of neurotransmitters that increases transiently the probability for the 
channel to be open or closed. G-protein-linked receptors activate or 
inactivate plasma-membrane-bound enzymes or ion channels via trimeric 
GTP-binding proteins (G proteins). Enzyme-linked receptors either act 
directly as enzymes or are associated with enzymes; the latter are usually 
protein kinases or phosphatases that phosphorylate or dephosphorylate
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specific proteins of the target cell. Through cascades of highly regulated 
protein phosphorylations, elaborate sets of interacting proteins relay most 
signals from the cell surface to the cytoplasm or to the nucleus, thereby 
altering the cell’s metabolism or the cell’s pattern of gene expression and, as 
a consequence, its behavior. Other signals are addressed to the regulation of 
cellular metabolic processes, such as glycogen breakdown, due to the 
activation of cyclic-AMP-dependent protein kinase (A-kinase) (Cohen, 
1983). Cross-talk between different signalling cascades enables a cell to 
integrate information from the multiple signals that it receives.
G PROTEINS
A large number of neurotransmitters, hormones and other extracellular 
ligands, but also light and odorants, elicit cellular responses by interaction 
with one receptor of the largest family, those coupled to G proteins. These 
receptors are cell membrane proteins characterized by seven hydrophobic 
membrane-spanning domains (Baldwin, 1994). They are coupled by 
heterotrimeric guanine nucleotide-binding regulatory proteins (G proteins) to 
intracellular effectors, either enzymes or ion channels, that generate 
intracellular signals leading to cellular responses. G protein-mediated 
signalling pathways have attracted a great deal of attention because of the
16
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Fig.l The G protein cycle. G protein-linked receptors contain seven 
transmembrane segments that form a ligand-binding site on the outside of the 
cell and a G protein-binding site on the inside. (1) When the ligand binds, (2) 
the receptor activates a G protein by causing the Ga subunit to release GDP 
and acquire GTP. (3) The G(a) and G((3y) subunits then separate and (4) 
initiate signal transduction events. (5) The GTP-G(a) subunit eventually 
hydrolyzes its bound GTP, converting the subunit back to its inactive GDP- 
G(a) form. (6 ) The inactive GDP-G(a) subunit then recombines with G((3y) to 
form the inactive G heterotrimer.
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many physiological and pharmacological processes modulated or mediated 
by these mechanisms.
Heterotrimeric G proteins consist of an a  subunit that binds and hydrolyzes
GTP together with a (3 and a y subunit (Casey and Gilman, 1988; Bimbaumer
1990; Bourne et al., 1990; Simon et al., 1991; Spiegel 1992; Neer 1995;
Hamm 1998). It is the identity of the a  subunit that defines the heterotrimer.
The p and y subunits are tightly bound to each other and are regarded as a
functional entity, the Py complex. To transmit a signal from the receptor to
effectors, the heterotrimeric G protein undergoes an activation-inactivation
cycle, which allows it to function as a molecular switch. In the inactivated
state, the a  subunit is bound to GDP and is tightly associated with the py
complex (Fig.l). In this form, the G protein can be recognized by an
appropriate receptor that has been activated by a specific stimulus. The
activated receptor binds to the heterotrimer and promotes the dissociation of
GDP from the a  subunit. GDP is then replaced by GTP, whose intracellular
concentration exceeds that of GDP by about 10 fold. The accepted model for
activation of the heterotrimer states that binding of GTP induces a
conformational change in the a  subunit that results in the dissociation of the
protein from receptor as well as from py complex. Both a-GTP and the Py
complex are able to interact with effector proteins and regulate their function.
Activation is terminated by the intrinsic GTPase activity of the a  subunit,
18
which hydrolyses GTP. GDP-bound a  reassociates with the free py complex 
and the heterotrimer is ready to enter a new cycle. Recent studies have 
reexamined this hypothesis, by using fusion proteins between the yeast 
Saccharomyces cerevisiae G P subunit (Ste4) and G a  subunit (Gpal) (Klein 
et al., 2000) or between the a  factor-receptor (Ste2) and Gpal (Medici et al.,
1997): both the chimeric proteins allow efficient signal transduction as 
effectively as when coexpressed as separate proteins. Hence, at least in yeast, 
dissociation of the heterotrimer by the receptor or dissociation of the a  
subunit by the Py complex is not required for the activation of the a  subunit. 
Some effectors, such as phospholipase Cp and the retinal cGMP 
phosphodiesterase appear able to accelerate hydrolysis of GTP by the a  
subunit (Berstein et al., 1992; Biddlecome et al., 1996; Arshavsky and 
Bownds, 1992). In addition, the recently identified proteins called regulators 
of G protein signalling (RGS) interact with GTP-bound a  subunits and 
stimulate their GTPase activity (Dohlman and Thomer, 1997; Arshavsky and 
Pugh, 1998; Berman and Gilman, 1998; Zerangue and Jan, 1998).Thus, RGS 
family members are thought to govern the strength and duration of 
physiological responses triggered by G protein-dependent signalling 
pathways.
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G protein a subunits
Heterotrimeric G proteins are a subset of a larger family of GTP-binding 
proteins. This larger family includes monomeric factors that control protein 
synthesis and a group of monomeric GTP-binding proteins, such as Ras, Rab 
and Rho, involved in the regulation of proliferation, intracellular transport, 
and other cell functions (Bourne et al., 1990; Kaziro et al., 1991). It is the a  
subunit of heterotrimeric G proteins that has structural and functional 
homologies with other GTP-binding proteins.
The elucidation of the crystal structure of GDP and GTP-bound transducin 
and ail has provided a picture of the molecular mechanism of guanine 
nucleotide binding and hydrolysis by G protein a  subunits (Neer, 1995). 
Basically, X-ray crystallographic analysis has revealed that G a subunits 
contain two domains: a domain involved in guanine nucleotide binding and 
GTP hydrolysis, which is homologous to other GTP-binding proteins, and a 
unique helical domain (Bourne et al., 1991; Spiegel et al., 1992; Hamm and 
Gilchrist, 1996). The GTPase domain contains the sites for binding Py 
subunits, receptors and downstream effectors. The helical domain seems to 
contribute to the stability of the guanine nucleotide binding site (Hamm,
1998). However, its main function is not yet known.
The C-terminal part of the a  subunit is involved in interaction with receptors. 
In particular, it has been shown that the last few residues of the protein
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contribute importantly to the specificity of receptor-G protein interaction 
(Conklin and Bourne, 1993; Bourne 1997; Hamm and Gilchrist, 1996). 
Mutational analysis and peptide mapping studies have narrowed down 
important interaction sites of Œg, and with their respective effectors
(adenylyl cyclase, cGMP phosphodiesterase and phospholipase Cp) to 
regions in the C-terminal half of the a  subunit (Berlot and Bourne, 1992; 
Rarick et al., 1992; Arkinstall et al., 1995). Finally, the N-terminus of the 
a  subunit and the effector binding site are important for interaction with the 
Py complex (Conklin and Bourne, 1993; Rens-Domiano and Hamm, 1995). 
More than twenty different mammalian G protein a  subunits have been 
described so far. On the basis of their sequence homology and common 
functional properties, they can be divided into four classes (Fig.2):
1) Ga*: this class includes Œg, that couples a large group of membrane 
receptors (such as the P-adrenergic receptor and the TSH receptor) to 
adenylyl cyclase, and that couples odorant receptors to adenylyl cyclase. 
In addition to the stimulation of adenylyl cyclase, it has been reported that 
Gag also activates dihydropyridine-sensitive Ca^^ channels in skeletal and 
cardiac muscle (Brown and Bimbaumer, 1988). Most tissues contain a 
mixture of two major forms of G that migrate with apparent molecular 
masses of 45 and 52 kDa. This heterogeneity arises from alternative splicing
21
Class Subunits Effectors and effects
as as, aoif Stimulation of adenylyl cyclase
aj/o ail, ai2, ai3 Inhibition of adenylyl cyclase 
Activation of channels
ao Inhibition of adenylyl cyclase
Regulation of B-Raf, Rap 1 GAP, the Stat3 and
MAPK pathways
az Inhibition of adenylyl cyclase
at Stimulation of cGMP phosphodiesterase
agust Regulation of bitter and sweet signalling 
pathway
aq,aii,ai4, ai5/i6 Stimulation of phospholipase C p 
Activation of tyrosine kinase Btk
ai2/i3 a%2, a%3 Activation of the GTPase CDC42, Rho, Rac 
Inhibition/stimulation of pi 15 RhoGEF 
Activation of Ras GAP 
Activation of the tyrosine kinase Btk
Fig.2. G protein a  subunits and some of their functions.
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of a single precursor mRNA, which results in polypeptides that contain 
(referred to as long form) or lack (short form) a sequence of 25 residues 
encoded by exon III of the gene for G Œg. In fact, as many as four splice 
variants appear to be produced by this mechanism, as each short and long 
form may include or exclude a single serine residue at the splice junction 
(Kozasa et al., 1988).
G Œg is sensitive to cholera toxin (CTX) that is able to catalyze ADP- 
ribosylation of an arginine residue (Arg201 in the long form of Œg). This 
modification affects the a  chain from two connected aspects: inhibition of 
the GTPase activity and persistent activation by the bound GTP. As a 
consequence, G raises intracellular cAMP levels independently o f the 
presence of extracellular signals. It is commonly known that the severe 
watery diarrhea characteristic of clinical infection with Vibrio cholerae is 
secondary to the direct effect of CTX on G oCg which induces the activation of
C r channels in intestinal epithelial cells, although Peterson and Ochoa 
(1989) analyzed the role of cAMP and prostaglandins in the pathogenesis of 
experimental cholera and demonstrated that cAMP accumulation triggers 
only a small, transient intestinal fluid accumulation response, while 
prostaglandin E is responsible for long-term water and electrolyte secretion 
in cholera.
Mutations in the gene encoding G Œg are involved in the development of
various human diseases (Spiegel et al., 1992). Interestingly, analysis o f DNA
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from human GH-secreting pituitary tumors and thyroid tumors revealed 
somatic mutations within the G gene that are single substitutions of 
residue Gln227 or residue Arg201 (the site of covalent modification by 
CTX). These substitutions inhibit the intrinsic GTPase activity of G and, 
in cells in which cAMP stimulates proliferation, lead to abnormal cell growth 
(Spiegel et al., 1992; Spiegel et al., 1993; Spiegel, 1995; Vallar, 1996). The 
mutant activated genes found in human tumors have been termed gsp (Gg 
protein) oncogenes (Landis et al., 1989).
2) G Œi/o. This group includes several types of a  subunits: a,, a^, a^, and 
agusf Although closely related, the a; subunits, a^ , and are encoded 
by different genes (Freissmuth et al., 1989). Several studies have shown that 
it is possible to assign the sequence encoded by the gene to a 41-kDa 
protein found in high concentrations in the brain, the a ;2 gene to a 40-kDa 
protein that appears to be relatively ubiquitously distributed, and the a^ g gene 
to a distinct 41-kDa protein whose distribution is prevalent in non neural 
tissues. The proteins referred as Ga^ and Ga^ are mainly expressed in the 
brain. The effectors and pathways regulated by the subunits have been at 
least partially characterized (Neer, 1995; Hamm, 1998), whereas the 
signalling functions of Ga^ and Ga^ are less clear. The two isoforms o f Ga^ 
or transducin (Ga^.r and Gat_c) are expressed exclusively in retinal rods and
24
cones, respectively, and link the photon receptor rhodopsin to the activation 
of a cyclic GMP phosphodiesterase. Gagust is a taste receptor cell-specific G 
protein closely related to the transducins that mediates both bitter and sweet 
signal transduction (Wong et ah, 1996).
Gaj and Ga^ are involved in the regulation of signalling systems that can be 
disrupted by pertussis toxin (PTX), as they all serve as substrates for this 
toxin. PTX modifies covalently the a  subunits by ADP-ribosylation of a 
cysteine residue four amino acids from the C-terminus (Bimbaumer et al., 
1990). In contrast to the modification produced by CTX, this alteration 
results in the uncoupling of the modified G protein from its activating 
receptor(s) and therefore in the disruption of signal transduction. PTX- 
sensitivity is a property which has greatly helped the elucidation o f the 
signals regulated by Ga, and Ga^. The block of many cellular responses by 
PTX implies therefore an involvement of Gi/o family members in a variety o f 
signalling pathways, from the inhibition of adenylyl cyclase to the activation 
or inhibition of several ion channels. The Gaj and Ga^ subunits interact with 
a large group of receptors (such as a2  adrenergic, M2 muscarinic, D2 
dopaminergic, somatostatin, thrombin and LPA receptors) and regulate 
many cellular responses. It is well established that the three proteins 
inhibit adenylyl cyclase (Bimbaumer, 1990). Several results have 
demonstrated that Gai2 is also involved in mitogenic signals. Mutationally
activated Gaj2 has been shown to deregulate cell growth in various systems
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and to induce transformation in a specific cell model, Rat-1 fibroblasts 
(Gupta et al., 1992). In addition, mutations that activate Gai2 have been 
detected in tumors of the ovary and of the adrenal cortex (Lyons et al., 1990) 
and in nonfunctioning pituitary adenomas (Williamson et al., 1994). It has 
been proposed that these mutations convert the Gaj2 gene into an oncogene, 
termed gip2 (Lyons et al., 1990). The intracellular events involved in the 
mitogenic action of Gaj2 are not completely understood. In Rat-1 fibroblasts 
Gai2 seems able to activate mitogen-activated protein kinase (MAPK) (Pace 
et al., 1991; Gupta et al., 1992). Recent results have shown that this subunit 
might activate the MAPK pathway by activation of RaplGAPII and 
reduction of intracellular GTP-bound Rapl (Mochizuchi et al., 1999). 
Additional information on the function of Gai2 comes from the analysis of 
transgenic animal models. Disruption of the murine gene encoding the a-^ 
subunit causes mice to develop an inflammatory bowel disease resembling 
human ulcerative colitis and also adenocarcinomas of the colon (Rudolph et 
al., 1995). Furthermore, using cells from transgenic mice harbouring 
inducible expression of RNA anti sense to the gene encoding Gaj2, Moxham 
and Malbon (1996) showed that Gaj2 deficiency in adipose tissue and liver 
produces hyperinsulinemia, resistance to insulin and impaired glucose 
tolerance. These effects are associated with increased protein-tyrosine 
phosphatase activity and attenuated insulin-stimulated tyrosine
phosphorylation of insulin-receptor substrate l(IRS-l). The authors
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suggested therefore that Gaj2 deficiency might be a model for insulin 
resistance characteristic of non-insulin-dependent diabetes mellitus, 
implicating Gtti2 as a positive regulator of insulin action.
G tto subunit
Strathmann et al. (1990) isolated cDNA clones encoding two forms of the G 
tto subunit from a mouse brain library. These appear to be the products of 
alternative splicing. Tsukamoto et al. (1991) likewise concluded that two 
different Ga^ mRNAs may be generated by alternative splicing of a single 
gene. The two forms have been named and ao2 (Price et al., 1990; 
Strathmann et al., 1990; Hsu et al., 1990 and Murtagh et al., 1991). These 
two subunits differ for 26 residues that are present only in ao2- Some tissues 
contain multiple Ga^ mRNAs of various sizes that differ in the 3-prime 
untranslated regions (UTRs). Murtagh et al. (1991) concluded that the Ga^ 
mRNAs with different 3-prime UTRs arise by alternative splicing of 
transcripts from a single gene. The UTRs were shown to exhibit a high 
degree of interspecies conservation and may play a role in regulation of Ga^ 
expression during differentiation or in specific tissues. Very recently a third 
Gao isoform, termed Gaos, has been purified from mammalian brain (Exner 
et al., 1999). It has been suggested that Gaos originates from an enzymatic 
deamidation of GŒqi by an as yet-unidentified activity. The possible 
functional differences between the various GŒq subunits have not been
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clearly established. However, it has been suggested that Gaoi and Gao2 might 
couple to different receptors (Kleuss et al., 1991). Ga^ has unique and 
interesting properties. It is the most abundant G protein a  subunit present in 
neurons, where it can constitute up to 2 % of the total membrane protein 
(Huff et al., 1985; Giershik et al., 1986; Asano et al., 1989). In addition to 
neurons, Ga^ appears to be expressed, albeit at much lower levels, in 
endocrine cells, heart, testis, skeletal muscle and uterus. Little or no can 
be detected in liver, kidney and spleen (Price et al., 1989; Strathmann et al., 
1990). Among cell lines, the protein is found in PC I2, GH3, and CHO cells 
but not in C0S7 cells (Wu et al., 1992; Law et al., 1993). This pattern of 
expression predicts that may play an important role in neuronal function. 
Indeed, analysis of transgenic mice lacking Ga^ has revealed that these 
animals suffer tremors and seizures, are hyperalgesic and display a severe 
motor control impairment (Valenzuela et al., 1997; Jiang et al., 1998). Jiang 
et al. (1998) disrupted the G gene in mice by homologous recombination, 
median survival was only 7 weeks. At the cellular level, inhibition of cardiac 
adenylyl cyclase by carbachol was unaffected, but opioid receptor-mediated 
inhibition of calcium channel currents was decreased by 30%. In 25% of the 
homozygous mutant cells examined, the calcium channel was activated at 
voltages lower than in their counterparts. Loss of Ga^ was not accompanied 
by appearance of significant amounts of active free Py dimers. Homozygous
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mutant mice were hyperalgesic and displayed a severe motor control 
impairment. Despite this problem, homozygous mutant mice were 
hyperactive and exhibited a turning behavior that had them running in circles 
for hours on end both in cages and in open-field tests. Except for one, all 
mutant mice turned counterclockwise. These results indicated that Gao plays 
a major role in motor control, motor behavior, and pain perception and 
predict involvement of Gao iii calcium channel regulation.
To analyze the function of Gao in the heart, Valenzuela et al. (1997) 
generated knockout mice lacking both forms of Gao by homologous 
recombination and studied the muscarinic regulation of calcium channels in 
cardiac muscles in Gao mice and controls. There was no difference in the 
effect of isoproterenol on the L-type voltage-dependent calcium channel in 
ventricular myocytes of both groups, but the inhibitory effect of 
carbamylcholine was almost completely abolished in the Gao group. This 
demonstrated that, in the heart, Gao is specifically required for transmission 
of signals from the muscarinic receptor to the L-type voltage-dependent 
calcium channel.
Despite these data, knowledge of effector systems that may be the targets of 
activated Gao is still very limited. For a long time, Gao was thought to be
involved in the regulation of N-type voltage-dependent Ca^^ channels. 
However, it has been recently elucidated that inhibition of these channels by
29
Go is mediated by the (3y and not the a  subunit of the heterotrimer (Ikeda, 
1996; Herlitze et al., 1996; Qin et al., 1997). In contrast, it is well established 
that Œo can directly inhibit a specific adenylyl cyclase form, type I, which is 
mainly expressed in brain (Sunahara et al., 1996). There is also evidence that 
Gao is able to regulate mitogenic signals and even to induce transformation: 
indeed, Kroll et al.(1992) demonstrated that expression of Q205L Gao, which 
lacks guanosine triphosphatase activity in NIH3T3 cells, results in 
transformation in a phospholipase C-independent manner. In CHO cells, it 
has been proposed that, the muscarinic M l and PAF receptors, which couple 
to both Gq and Go, activate a Gao-dependent pathway leading to MAPK 
stimulation (van Biesen et al., 1996). Recent studies (Antonelli et al., 2000) 
have shown in the same cell system that activated Gao is unable to induce 
MAPK activation but strongly potentiates the stimulatory effects of the EGF 
receptor. This effect was not associated with changes in the state of tyrosine 
phosphorylation of the EGF receptor. The activated mutant Gao-Q205L also 
potentiated MAPK stimulation by activated Ras. In CHO cells, EGF 
receptors activate B-Raf, but not Raf-1 or A-Raf. It was found that 
expression of activated Ga^ stimulated B-Raf activity independently of the 
activation of the EGF receptor or Ras. Inactivation of protein kinase C and 
inhibition of phosphatidylinositol-3 kinase abolished both B-Raf activation 
and EGF receptor-dependent MAPK stimulation by G a^. Moreover, G a^
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failed to affect MAPK activation by fibroblast growth factor receptors, which 
stimulate Raf-1 and A-Raf but not B-Raf activity. These results suggest that 
Gao can regulate the MAPK pathway by activating B-Raf through a 
mechanism that requires a concomitant signal from tyrosine kinase receptors 
or Ras to efficiently stimulate MAPK activity (Fig. 3). Further experiments 
have shown that receptor-mediated activation of Gao caused a B-Raf 
response similar to that observed after expression of the mutant subunit. The 
finding that Gao induces Ras-independent and PKC- and PI3 kinase- 
dependent activation of B-Raf and conditionally stimulates MAPK activity 
provides direct evidence for intracellular signals connecting this G protein 
subunit to the MAPK pathway. Another recent study has shown that G ao can 
directly interact with Rapl GAP (Jordan et al. 1999). The authors propose 
that Gao in its resting state sequesters Rapl GAP and, once activated, releases 
this regulatory protein, thereby controlling Rapl activity. Finally, by parallel 
experiments. Ram et al. (2000) studied the roles of the MAP kinases and 
Stat3 in transformation of NIH3T3 cells by Gao-Q205L. Expression of Gao- 
Q205L in NIH3T3 cells activated Stat3 but not MAPKl or 2. Coexpression 
of dominant-negative Stat3 (Signal transducer and activator of transcription 
3) inhibited Gao-Q205L-induced transformation of NIH3T3 cells and 
activation of endogenous Stat3. Furthermore, Gao-Q205L expression 
increased activity of the c-Src, and the Gao-Q205L-induced activation of
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Fig.3 Model of signalling pathways regulating Raf and MAPK in CHO cells.
The EGF receptor (EGFR) activates Ras and B-Raf, whereas the FGF receptor
(FGFR) activates Ras, Rafl, and A-Raf Activated Ga^ potentiates MAPK
activation by Ras and EGFR but not FGFR. The G protein subunit stimulates the
kinase activity o f B-Raf by a Ras-independent and PKC-and PI3K-dependent
mechanism, which is insufficient to promote MAPK activation. It is proposed that
this mechanism can efficiently stimulate the MAPK pathway in the presence o f a B-
Raf-activating signal from Ras or the EGFR. The dopaminergic D 2 receptor (D2 R),
which couples to both Gj and Gq, appears to stimulate MAPK through Ras
activation o f Raf-1. This effect is presumably mediated by G protein Py complexes
and, possibly, Ga; subunits. Upon stimulation o f this receptor, the Ras-independent
and PKC- and PI3K-dependent activation o f B-raf induced by Ga^ does not produce
a MAPK response.
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s tats was blocked by expression of CSK, which inactivates c-Src. Ram et al. 
(2000) concluded that Stat3 can function as a downstream effector for Ga^- 
Q205L and mediate its biological effects. Regulation of B-Raf, Rapl GAP, 
the Stat3 and MAPK pathways might explain how Ga^ can regulate cell 
growth. Other reported effects of Ga^ include stimulation of 
polyphosphoinositide hydrolysis and PKC activity in Xenopus oocytes 
(Moriarty et al., 1990; Kroll et al., 1991), activation of a Src-like kinase 
pathway in neurons (Diversè-Pierluissi et al., 1997) and inhibition of cardiac 
L type Ca^^ currents (Jiang et al., 1998). How these effects come about has 
not been established. Cumulatively, these studies suggest that, in order to 
elicit its wide biological effects, Ga^ may be able to engage into several 
distinct signalling pathways.
Finally, it is worth mentioning that there is evidence that Ga^ might be
activated not only by seven transmembrane domain receptors but also by
other proteins: GAP43, an intracellular growth cone-associated protein
involved in neurite outgrowth (Strittmatter et al., 1990); and the Alzheimer
amyloid protein precursor protein responsible for familial forms of this
disease (Nishimoto et al., 1993). Additionally, it has been proposed that Ga^
is not only involved in signal transmission but also in the regulation of the
secretory process. In C6  glioma cells, Gaoi has been detected on the
membrane of small intracellular vesicles and appears to regulate secretion of
the protease nexin-1 (Lagriffoul et al. 1996). In chromaffin cells, Ga^
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associated with secretory organelles has been proposed to regulate the ATP- 
dependent priming of exocytosis, by affecting the actin cytoskeleton. This 
effect might be related to the Rho-dependent activation of a PI4K localized 
on the membrane of secretory granules (Gasman et ah, 1998). Furthermore, 
in PC I2 cells the Gao2 subunit present on the membrane of secretory 
vesicles, seems to control catecholamine uptake (Ahnert-Hilger et al., 1999). 
These results suggest a function of Gao2 in regulation of neurotransmitter 
storage.
Light response of retinal ON bipolar cells seems to be regulated by Ga^ 
subunit. Retinal ON bipolar neurons detect the glutamate released by rods 
and cones via metabotropic glutamate receptor 6  (mGluR6 ), whose cascade is 
unknown. By studies of the retina in Ga^ -/- mice, Dhingra et al. (2000) 
found that the b-wave of the electroretinogram, both rod- and cone-driven 
components, was entirely missing. Further electroretinography performed on 
mice deficient for one splicing variant or the other have shown that the 
positive b-wave requires but not a ^2 (2 0 0 2 ).
Parallel work by Chen and Lambert was focused on the analysis o f the Gi/o
proteins-mediated presynaptic inhibition at rat hippocampal synapses. By
adenoviral expression of mutant PTX-insensitive subunits in cultured cells,
they found that rescued adenosine-induced presynaptic inhibition and the
rapid onset of the response was mediated by a RGS protein. By two-yeast
hybrid system, Traver et al. (2000) isolated a novel RGS protein, RGS 14,
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which is highly expressed in hippocampus; deletion analysis as well as in 
vitro binding experiment have shown that RGS 14 is able to bind to Rap 
protein and, over other G a subunits, preferentially to a^ . Very recently, 
Straiker et al. (2002) have confirmed previous results from Chen and 
Lambert by the same experimental approach.
In the heart, reactive oxygen species (ROS) have important functions in 
ischaemia/reperfusion-induced cardiac injury and in cytokine-stimulated 
hypertrophy. Extracellular signal-regulated kinase (ERK) is one of the ROS- 
responsive serine/threonine kinases. In vitro studies by Nishida et al. (2000) 
have found that treatment of rat neonatal myocytes with H2O2 activates Ga^ 
and Gaj subunits ina receptor independent manner, leading to the increased 
activity of ERK. Further mass spectrometry studies have demonstrated that 
H2O2 effect consists of two steps: the first step is the modification of Cys^^ ,^ 
leading to subunit dissociation. The second step is the modification of Cys^^ ,^ 
resulting in the increased rate of GDP dissociation (Nishida et al., 2002).
3) Gaq: this class includes Ga^, G an , G a^  and Ga^^n^ which mediate 
phospholipase C (PLC) activation by membrane receptors such as the a l  
adrenergic, the M l muscarinic and the TRH receptor.
Gaq is a 42 kDa protein originally purified from liver plasma membranes 
(Taylor et al., 1990) and cloned from mouse brain (Strathmann and Simon,
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1990). Recent studies of Bence et al. (1997) have revealed that, in addition to 
PLC, Gttq can directly stimulate the non-receptor tyrosine kinase Btk.
Gq and Gn are widely distributed in mammalian tissues, as demonstrated at 
the mRNA (Strathmann and Simon, 1990) and protein (Pang and Stemweis, 
1990) levels. Studies on Gttq in transgenic mice have shown that this subunit 
is particularly important in platelet function. Disruption of the Gttq gene 
provokes unresponsiveness of the platelets to a variety of physiological 
activators, thus leading to increased bleeding times and protection from 
collagen and adrenaline-induced thromboembolism (Offermanns et al., 
1997a). Gtti4 is most abundant in spleen, lung, kidney and testis, whereas 
G ai5 and G ai6 are confined to the hematopoietic cells (Wilkie et al., 1991; 
Amatruda et al., 1991).
4) G ai2/i3 : G aj2 and Ga^g are ubiquitously expressed and appear involved in 
several signalling pathways. They can elicit various responses: activation of 
both the Cdc42/Rac and the Jun kinase pathway; stimulation or inhibition of 
the MAPK pathway and of the Rho-dependent regulation of the cytoskeleton. 
The effectors and mechanisms of action of a  subunits of these G proteins 
have not been clearly established. Jiang et al. (1998) have shown that G0C12 
binds directly to, and stimulates the activity of the tyrosine kinase Btk and of 
a Ras GAP, Gaplm. Other studies have revealed that the GTPase activities of
36
G ai2 and Ga^g are stimulated by the Rho guanine nucleotide-exchange factor 
p l l 5  RhoGEF (Hart et al., 1998; Kozasa et al., 1998). Activated Ga^g binds 
tightly to p i 15 RhoGEF and enhances its stimulation of nucleotide exchange 
on Rho. In contrast, activated G a %2 inhibits this stimulation by Ga%g. Thus, 
p i 15 RhoGEF may act as an intermediary in the regulation of Rho proteins 
by Gi2 and Gig.
Disruption of the gene encoding Ga%g in mice impairs the ability of 
endothelial cells to develop into an organized vascular system, with ensuing 
intra-uterine death (Offermanns et al., 1997b). In addition, Gaig (-/-) 
embryonic fibroblasts show greatly impaired migratory responses to 
thrombin. These results demonstrate that Gttig participates in the regulation 
of cell movement in response to specific ligands as well as during 
developmental angiogenesis.
G protein py subunits
Five P subunits and more than ten y subunits have been identified (Simon et 
al., 1991; Clapham et al., 1997). With the exception of the brain specific pg 
subunit, which is only 50% identical to the others, P subunits show a high 
degree of homology (79-90%) (Watson et al., 1994). P subunits migrate as 
35-36 kDa proteins and are composed of seven repetitive segments of
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approximately 40 amino acids that contain a characteristic tryptophan- 
aspartic acid pair (WD-40 repeats) (Neer, 1995; Hamm, 1998). By contrast, 
G protein y subunits (5-10 kDa) are more heterogeneous. Functional 
differences between Py complexes may thus be primarily due to the nature of 
the Y subunit. Most p and y subunits appear to be able to form complexes; a 
few combinations, however, are never formed (Neer, 1995; Clapham and 
Neer, 1997). In addition, it is not clear whether within the cell the various a  
subunits associate randomly with Py complexes, generating many different 
heterotrimers, or whether preferred combinations of G a and GPy do take 
place. A great diversity in the number of heterotrimer combinations has been 
observed (Wilcox et al., 1995). Experiments involving synthesis inhibition of 
specific G a, GP or G y subunit suggest that defined aPy combinations carry 
out specific functions (Kleuss et al., 1992, 1993). Some a  subunits are 
myristoylated at the N-terminal glycine (a^  ai, a  %) and this modification is 
necessary for both membrane attachment and facilitated binding of py (Neer, 
1995). The y subunits differ from each other in the prenyl group bound to 
their C-terminal cysteine (Neer, 1995); prénylation and/or further carboxyl- 
terminal processing of y are not necessary for py formation, but are 
indispensable for high affinity interactions of Py with either G protein a  
subunits or adenylylcyclases (I-iguez-Lluhi et al., 1992).
The role of the py complex was long thought to be limited to the regulation
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of GDP dissociation from G a and the facilitation of G a activation by 
receptors. In the case of Gi/o proteins, this pathway is disrupted by PTX as 
Gi/o OG subunits are ADP-rybosilated by this toxin which prevent them from 
coupling to the receptor. More recent evidence has clearly established that 
free GPy can regulate specific effectors. In fact, the GPy complex stimulates 
phospholipase C, stimulates or inhibits enzymes of the adenylyl cyclase 
family, activates PI3Ky, activates inwardly rectifying channels and 
inhibits N-type Ca^^ channels (Neer, 1995; Clapham and Neer, 1997; Hamm, 
1998). Yan and Gautam (1996) have shown that the p and not the y subunit 
interacts with adenylyl cyclase type II and the inwardly rectifying 
channel, GIRKl. The region involved in the interaction is a specific N- 
terminal fragment of 1 0 0  residues present in both target proteins.
A primary role of the Py complex in the stimulation of the MAPK cascade 
has also been proposed by several studies (Hamm, 1998). GPy can activate 
PI3Ky which is able to increase the activity of a Src kinase leading to 
tyrosine phosphorylation of She (src homolog and collagen), formation of a 
Shc-Grb2 (growth factor receptor binding protein) complex and Ras- 
dependent activation of the MAPK cascade (van Biesen et al., 1996b; 
Gutkind, 1998).
Other potential Gpy effectors include the non receptor tyrosine kinases, Btk
and Tsk, and the membrane-bound enzyme phospholipase A2 (Clapham and
Neer, 1997; Hamm, 1998). It has also been reported that Py subunits
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negatively regulate dynamin I GTPase activity (Lin and Gilman, 1996) and 
interact with Rafl (Pumiglia et al., 1995). It should be finally mentioned that 
another role of the Py complex in cellular signalling is the membrane 
targeting of the P-adrenergic receptor kinase, PARK, involved in 
deseiisitization of the receptor response (Touhara et al., 1994). Several 
studies have addressed the question of functional differences between 
different py combinations with regard to effector regulation. With the 
exception of P^y ,^ which is only found in the retina, no profound differences 
between Py complexes have been detected (Neer, 1995; Hamm, 1998). Some 
recent data support, however, a specialized role for the Pg subunit in cell 
signalling. It has been shown that the Pgy2 dimer differs from dimers 
containing the Pi subunit in the specificity of effectors (Lindorfer et al., 
1998). Further studies have revealed that, after expression in Sf9 cells, GPg, 
but not GPi.4, forms cytosolic complexes with RGS6  and RGS7 which, 
unlike conventional GPy complexes, do not form heterotrimeric complexes 
with either Gtto-GDP or Gttq-GDP, but are able to inhibit piy2-mediated 
activation of PLC P2 (Posner et al., 1999). The precise role of RGS/Pg 
complexes in signal transduction remains, however, to be established.
PHOSPHOINOSITIDE HYDROLYSIS
Upon binding to their cell surface receptors, many extracellular signalling
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molecules including neurotransmitters, hormones, growth factors, and 
immunoglobulins elicit intracellular responses by activating PLC. Activated 
PLC catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) 
with generation of diacylglycerol and inositol 1,4,5-trisphosphate (IP3). 
Diacylglycerol is a direct activator of protein kinase C (PKC) (Nishizuka et 
al., 1992), whereas IP3 induces release of Ca^ "^  from the endoplasmic 
reticulum into the cytoplasm (Berridge, 1993). This bifurcating pathway lies 
at the root of a transmembrane signal transduction mechanism that regulates 
a large array of cellular processes, including metabolism, secretion, 
contraction, neuronal activity, and proliferation. The second messenger IP3 
has a key role in controlling both the mobilization of internal stores and the 
entry of external calcium. Cells generate IP3 through two major signalling 
pathways. In one pathway, receptors are coupled through G proteins to 
stimulate PLC P, whereas the other pathway depends upon tyrosine kinase- 
linked receptors which are specifically coupled to PLC y.
PHOSPHOLIPASE C
Direct protein isolation and molecular cloning studies have revealed the 
existence of multiple PLC isozymes in mammalian tissues (Rhee et al., 1989; 
Rhee et al., 1992). As predicted from the cDNAs, the PLC isozymes vary in 
size, with molecular masses ranging from 85 to 260 KDa. Despite the low
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overall homology among the amino-acid sequences, significant similarity is 
apparent in two regions (one of about 170 residues and the other of about 
260 residues) that are designated as the X and the Y domains. These domains 
appear essential for the catalytic activity of the enzymes (Meldrum et al., 
1991; Lee and Rhee, 1995). Eighty amino-acids are either invariant or 
conservatively changed in each of the X and Y regions of many PLC 
sequences, whereas only 8 amino-acids are conserved outside these two 
regions. Because all of the latter 8 conserved amino acids are located at the 
amino-terminal side of the X region, the line of demarcation of the start of 
the X region is not clear-cut. All PLCs contain an N-terminal region of about 
300 amino acids that precedes the X region and contains a pleckstrin 
homology (PH) domain.
On the basis of the relative locations of the X and Y domains in the primary 
structure, PLC isozymes are classified into four types: P, y, Ô and 8 (Fig.3). 
Interestingly, the C-terminal sequence following the Y domain is about 450 
aminoacid long in PLC-P and is almost non-existent in PLC- 5. The PLC 
originally defined as a  in sheep seminal vesicles is probably a proteolytic 
product of a 5 isozyme (Exton, 1996), and the cDNA originally reported for 
PLC a  encodes a protein-disulfide isomerase (Exton, 1996).
All four types of PLC catalyze the hydrolysis of the three common inositol 
containing phospholipids: phosphatidylinositol (PI), phosphatidylinositol 4- 
monophosphate (PIP), and PIP2, though PIP and PIP2 are the preferred
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substrates. PIP and PIP2 are produced by phosphorylation of 
phosphatidylinositol. In most cell types, PIP2 constitutes less than 10% of the 
total inositol lipids and less than 1% of the total phospholipids. Although all 
three inositol phospholipids may be broken down in the signalling response, 
the breakdown of PIP2 is most critical, even though it is the least abundant 
(Ryu et al., 1987). The catalytic activities of all three types of PLC are 
dependent on Ca^ .^ The 0-type isozymes are more sensitive to this cation. 
Stmctural and mutational studies have identified residues within the catalytic 
domain that likely contribute to substrate recognition, Ca^  ^ binding, and 
catalysis (Ellis et al., 1998). The crystal structures of complexes of PLC 51 
with Ca^  ^ and Ins(l,4 ,5 )P3 reveal the complex interactions of Ca^  ^ with 
several negatively charged residues (Glu^"^\ Asp^ "^ ,^ and Glu^^°)and Asn^^  ^in 
the active site as well as with the 2-hydroxyl group of Ins(1,4,5)P3 (Essen et 
al., 1996; Ellis et al., 1998).The importance of all four these amino acid 
residues in coordination of Ca^  ^was demonstrated by analysis of the PLC 
activity of the respective point mutants at various concentrations of Ca^  ^
(Ellis et al., 1998).
The C2 domains of PLC isozymes comprise -120 residues, and such domains 
are present in many proteins that interact with lipid membranes. The C2 
domain of PLC 51 has been estimated to contain three to four Ca^  ^binding 
sites. Calcium ions bound to the C2 domain of were recently shown to 
enhance enzyme activity (Lomasney et al., 2001). In contrast, the C2
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domains of PLC P isozymes exhibit no apparent affinity for membrane 
bilayers in the presence of Ca^ ,^ but they do interact with activated a  subunits 
of Gq proteins (Wang et al., 1999).
The role of the EF-hand domains of PLC isozymes is not clear. 
Crystallographic data suggest that the EF-hand domain of does not bind Ca^  ^
but rather serves as a flexible link between the PH domain and the rest of the 
enzyme, thus allowing the C2 and catalytic domains to interact with the 
membrane after binding of the PH domain to PtdIns(4 ,5 )P2 (Ellis et al., 1998; 
Essen et al., 1997). However, more recent evidence indicates that the EF- 
hand domain of PLC Ô1 does bind Ca^^and that the bound Ca^  ^ is necessary 
for the efficient interaction of the PH domain with PtdIns(4 ,5 )P2 (Yamamoto 
et al., 1999).
The different types of PLC differ in their subcellular localization. When 
tissues are homogenized in low ionic strength buffers, PLC P isozymes are 
recovered predominantly in the particulate fraction whereas PLC y and PLC 
Ô are detected mainly in the cytosolic fraction (Exton, 1996). Association of 
PLC y l with the cytoskeleton has also been described (Me Bride et al., 1991; . 
Yang et al., 1994). Several studies have shown localization of PLCs in nuclei 
(Exton, 1996). In particular, PLC p i has been reported to be localized 
exclusively in the nucleus of Swiss 3T3 cells (Martelli et al., 1992). The 
physiological role and activation mechanism of nuclear PLCs are unclear.
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Fig.4. Phospholipase C family. Domain organization of the four types of 
PLC isozymes. The X and Y catalytic domains as well as the PH, EF-hand, 
C2, SH2, SH3, RasGEF, and RA domains are indicated (Rhee SG, 2001).
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The various PLC families differ in their modes of activation in response to 
extracellular stimuli. PLC P enzymes are regulated by G proteins and PLC y 
by tyrosine kinases. At the moment the mechanism of regulation by receptors 
at the cell surface of PLC 6  is still unclear or even if it is at all; it is possible 
that PLC Ô enzymes are regulated only by calcium ions (Irvine, 1996). 
Although the various members of each family can be distinguished by their 
structural features and their expression patterns, it is not clear what roles the 
isoenzymes of a given PLC family play in vivo, or to what extent they 
determine the specificity of individual signalling pathways.
In this thesis, PLC-ys, PLC-ôs and PLC-es will be described only briefly, 
while the PLC P isozymes involved in G protein signalling pathway will be 
discussed in detail.
PLC y
The PLC-y enzymes are activated by polypeptide growth factors, that bind to 
receptors with an intrinsic tyrosine kinase activity, such as PDGF, EGF, FGF 
and NGF (Rhee and Choi, 1992; Pawson and Schlessinger, 1993). Other 
receptors that lead to the activation of PLC y are not protein kinases 
themselves but activate intracellular non-receptor tyrosine kinases (Lee and 
Rhee, 1995). Such receptors include the T cell antigen receptor, the 
membrane associated IgM, the high affinity IgE receptor, the IgG receptors 
and several receptors for cytokines.
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Activation of PLC y by growth factors has been studied in many cellular 
systems (Pawson and Schlessinger, 1993). Binding of the growth factors to 
their receptors results in receptor homodimerization and activation of the 
intrinsic tyrosine kinase activity. The phosphotyrosine residues of the 
autophosphorylated receptors provide high affinity binding sites for several 
proteins containing Src homology SH2 domains. These include PLC- 
y. Whilst PLC- p and PLC- ô contain short sequences of 50-70 amino acids 
separating the X and Y regions, PLC- y has a long sequence of about 400 
amino acids which contains the so called Src homology SH2 and SH3 
domains (Koch et al., 1991) (see Fig.3). Bound PLC y  is activated by the 
tyrosine kinase receptor through tyrosine phosphorylation (Rhee and Choi, 
1992; Exton, 1996).
PLC y is one of many signalling proteins known to be activated upon 
stimulation by growth factors. Several studies have shown that PLC y 
activation and the consequent increase in second messenger production 
contributes to cell proliferation in response to growth factors (Rhee and 
Choi, 1992; Exton, 1996). In addition, several lines of experimental evidence 
suggest that PLC y may regulate actin polymerization by reducing the 
concentration of PIP2 (Exton, 1996).
Two PLC isozymes participate in these pathways: PLC- y l and - y2 (Lee and 
Rhee, 1995). PLC- y l has been studied more extensively than PLC- y2,
which is mainly expressed in haemopoietic cells. Both the enzymes appear to
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be activated by non receptor PTKs, even if the ratio of PLC- y2 to PLC- 
y l concentrations and the relative extents of phosphorylation differ 
significantly between the respective haemopoietic cell types (Rhee and Choi, 
1992).
Up-regulated signaling from the epidermal growth factor receptor (EGFR) 
has been correlated with tumor invasion and metastasis in numerous human 
neoplasias. Turner et al. (1997) have demonstrated that increased levels of 
EGFR promote invasiveness of human prostate carcinoma DU-145 cells. To 
analyse the increased cell-motility signaled via PLC y activation, highly 
invasive DU-145 cells engineered to overexpress the EGFR were stably 
transfected with PLC z, a dominant-negative fragment of PLC y which 
consists of SH2/SH3 domains and an inhibitor (I) domain (Homma et al.,
1992). Tumors from the cells expressing PLC z fragment were significantly 
less invasive than control cells. Similar results have been obtained recently in 
bladder carcinoma cell lines (Kassis et al., 2002). These data suggest that 
PLC y could represent a potential therapeutic target to limit tumor 
progression promoted by up-regulated signaling from the EGFR and related 
receptors with intrinsic tyrosine kinase activity.
PLC 5
In contrast to the PLC y isozymes, the receptor-linked activation 
mechanism(s) of PLC Ô has not been fully clarified. So far the family
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includes four mammalian isozymes: Ô1, 52, 53 and Ô4. Molecules similar to 
members of the PLC 6  family are the only PLC types that have been isolated 
from simple organisms such as yeast and slime mould (Exton, 1996). PLC 8  
is insensitive to the activation of G Œq, G py or tyrosine phosphorylation 
(Exton, 1996). As described above, the sensitivity of PLC 8  isozymes to Ca^ "^  
is greater than of the other isozymes. Calcium promotes both the association 
of the PH domain with PtdIns(4,5)P2 as the result of its binding to the EF- 
hand domain (Yamamoto et al., 1999) as well as the formation of a C2 
domain-phosphatidylserine-Ca2+ ternary complex as the result of its binding 
to the C2 domain (Lomasney et al., 1999). Banno et al.(1994) revealed that 
thrombin stimulation of CHO cells overexpressing PLC- 81 is able to induce 
activation of the enzyme via both G proteins and Ca^ *^ . The activity of both 
PLC 81 and PLC 84 is clearly stimulated by Ca^^ (Lee and Rhee, 1996). 
Recent studies have demonstrated by using a peptide approach and site- 
directed mutagenesis, that multiple regions of tissue type transglutaminase 
(TGII) interact with the alB -A R  and that the alB -A R  (alpha IB 
adrenoreceptor) stimulates PLC 8  via TGII (Feng et al., 1999). This novel 
potential regulator of PLC 8  isozymes was termed high molecular weight G 
protein or Gh (75-80 kDa). This protein, which also possesses tissue 
transglutaminase activity, forms a complex with PLC 81 in cells stimulated 
through a  1-adrenergic, oxytocin receptor or interacts with thromboxane A2
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receptor, increasing PLC activity. Recently it has been shown that the free or 
GDP-bound form of Gh are associated to PLC Ô1 (Murthy et al., 1999), which 
suggests that the activity of PLC Ô1 might be inhibited by Gh in unstimulated 
cells and that such inhibition might be attenuated by the binding of Gh in 
response to receptor occupancy.
PLC 8
PLC 8 protein is the homolog of PLC 210, which was initially identified from 
a Caenorhabditis elegans cDNA library and contains several domains not 
apparent in other known PLC isoforms. The recently identified human PLC 8 
has been detected in two alternative splicing forms with molecular sizes of 
230 and 260 kDa. The mRNAs encoding these enzymes are present in a wide 
variety of human tissues, most abundantly in the heart. Both the variants 
differ from the other three types of isozymes in that they do not contain a PH 
and EF-hand domains but possess an NH2-terminal Ras guanine nucleotide 
exchange factor (RasGEF)-like domain and at least one and pheraps two 
COOH-terminal Ras binding (RA) domains. There are many evidences which 
support a possible role for PLC 8 as GDP-GTP exchange factor for, as well 
as an effector of, Ras (Gao et al., 2001). PLC 8  also appear to be activated by 
G ai2 (Lopez et al., 2001).
PLC P
The PLC P family includes four subtypes: p i, P2, P3 and P4. Structural
studies have revealed that the long C-terminal domain, that characterizes all
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these enzymes, mediates their membrane localization (Kim et al., 1996) as 
well as their interaction with G protein Œq subunits (Park et al., 1993; Wu et 
al., 1993). Amino acid analysis of PLC p isozymes predicts that most of the 
C-terminal domain is helical, and three regions in this domain contain a high 
proportion of basic residues that are highly conserved (Lee et al., 1993). 
Projection of the sequences of these three regions as helical wheels reveals 
clustering of the basic residues. The role of the C-terminus and the clustered 
basic residues in PLC P was investigated by substitution of clusters of basic 
residues in different regions (Kim et al., 1996): none of the basic clusters 
appeared critical for particulate association, but all contribute to the 
association, presumably by interacting with acidic residues in the particulate 
fraction. Other studies have shown that, in addition to the C-terminus, the PH 
domain, known to bind PIP2, is able to mediate membrane localization of 
PLC p isozymes (Kim et al., 1996).
PLC P 1
Phospholipase C Pl exists as two polypeptides of 150 and 140 kDa and is 
encoded in rat brain by two distinct transcripts of 5.4 and 7.2 kb (Suh et al., 
1988). A cDNA corresponding to the entire 5.4-kb transcript revealed an 
open reading frame that encodes a 1216-amino acid polypeptide (Suh et al., 
1988). Subsequently, Bahk et al. (1994) isolated the cDNA corresponding to 
the entire 7.2-kb transcript from a rat brain cDNA library. The 7.2-kb 
transcript differs from the previously reported 5 .4 -kb transcript by possessing
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both an additional 118 nucleotides located near the end of the coding 
sequence and a 1738-nucleotide extension of the 3 '-flanking region. The 
presence of the 118-nucleotide insert in the 7.2-kb sequence gives rise to an 
open reading frame that codes for a 1173-aminoacid polypeptide (PLC plb), 
thé C-terminal sequence of which differs from that of the 1216-aminoacid 
polypeptide derived from the 5.4-kb transcript (PLC Pla). Analysis of PLC 
p i genomic DNA revealed that PLC p la  and PLC p lb  are derived from a 
single gene by alternative RNA splicing (Bahk et al., 1994).
Studies of expression with antibodies able to recognize the 150-kDa enzyme 
as well as the 140-kDa variant showed that both proteins are expressed in 
much higher concentrations in the brain than in other tissues (Jhon et al.,
1993). Analysis of PLC pl-/- mice has revealed that this enzyme is 
particularly important in signal transduction by muscarinic acetylcholine 
receptors in the cerebral cortex and hippocampus. As a consequence, PLC 
pl-/- mice develop epilepsy (Kim et al., 1997).
PLC P2
The PLC p2 cDNA was cloned and sequenced from HL-60 cells using 
PLC p i cDNA as a probe under reduced stringency hybridization (Park et al.,
1992). The cDNA encodes a putative polypeptide of 1181 amino acids with a 
calculated molecular mass of 133 kDa. Its pattern of expression has not been 
extensively characterized, but appears to be very limited (Jhon et al., 1993; 
Ali et al., 1997).
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As will be discussed below, PLC P2 can be efficiently activated by G Py 
subunits (Katz et al., 1992; Wu et al., 1993). Wu et al. (1993) have found that 
the N-terminal half of the molecule contains the sequences required for 
activation by G Py. The G Py-binding region of PLC p2 has been more 
recently narrowed to 62 amino acids (residues Leu-580 to Val-641) (Kuang 
et al., 1996) (see Fig.3).
PLCp3
PLC P3 was cloned and sequenced from rat thyroid FRTL5 cells (Jhon et al.,
1993). The apparent size of the enzyme is 132-kDa. A distinctive feature of 
PLC P3 is that the X and Y domains are separated by 121 residues compared 
with 70 and 76 residues in PLC Pl and PLC P2.
PLC P3 appears to be the most widely expressed member of the PLC 
P family, particularly abundant in brain, parotid gland, liver and uterus (Jhon 
et al., 1993). The precise functional role of PLC P3 remains to be defined. 
Weber et al. (1994) have found that the PLC P3 gene shows loss of 
expression in tumors from endocrine pancreas, the adrenal cortex, and the 
thyroid medulla, but the implications of this finding are not clear (Weber et 
al., 1994).
PLC P4
PLC P4 was identified by several groups using different approaches. Min et
al. (1993a,b) purified a novel PLC from bovine cerebellum and identified this
enzyme as PLC P4 by comparing the partial aminoacid sequences with the
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sequences of other PLC isozymes and by analyzing immunological cross­
reactivity. Kim et al. (1993) cloned and sequenced the cDNA corresponding 
to PLC p4 from a rat brain cDNA library. This encodes a putative 
polypeptide of 1176 amino acids, with a calculated molecular mass of 130 
kDa. In parallel, Lee et al. (1993) purified from a retinal particulate fraction 
a PLC preparation that contained a major protein band with an apparent 
molecular mass of 130 kDa. Analysis of tryptic peptides derived from the 
130-kDa protein revealed a sequence corresponding to the enzyme PLC P4. 
A search of a rat brain cDNA library by PCR with oligonucleotide primers 
based on common PLC aminoacid sequences resulted in the cloning of the 
full-length cDNA. Bovine PLC P4 cDNAs were also isolated by Ferreira et 
al. (1993) using conserved regions of the cDNA encoding the Drosophila 
PLC norpA (no receptor potential). Indeed, PLC |34 is highly homologous 
(50%; Kim et al., 1993) to the norpA protein (Pak et al., 1970). GTPase 
sequence motifs present in proteins of the GTPase superfamily are found 
conserved in PLC P4 as well as norpA but not in other phospholipases C 
(Ferreira et al., 1993). These motifs G1-G5 have been shown to be important 
for GTP binding and GTPase activity (Kaziro et al., 1991). Motifs G1-G4 are 
strictly conserved, while G5, which is poorly conserved or even absent in 
other GTPases as well, is partially conserved. Motifs G1-G3 are found in box 
X, while G4 and G5 are in box Y and extended box Y, respectively; thus all
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five motifs are found in all four variants of the protein. Actually, the 
functional role of these conservative regions has not yet been clarified.
The expression pattern of PLC P4 has not been extensively characterized. 
The enzyme has been detected in brain, retina and pituitary gland (Alvarez et 
al., 1995). In the brain, PLC P4 mRNA is highest in the cerebellum and is 
almost negligible in the cerebral cortex and hippocampus (Tanaka and 
Kondo, 1994).
Four alternative bovine forms of PLC p4 expressed preferentially in the 
retina, have been identified. These variants are characterized by different N- 
terminal regions and by the presence or absence of 36 nucleotides within the 
region between boxes X and Y (Ferreira et al., 1993). Interestingly, a cDNA 
sequence predicting a human PLC p4 polypeptide of 1022 amino-acid 
residues (117 kDa) has been isolated from a human retina library by Alvarez 
et al. (1995). This PLC p4 variant lacks the 165-aminoacid N-terminal 
domain present in the rat brain enzyme, but has a distinctive exon 1 unique 
for human and bovine retina isoforms (Fig.5).
In addition to these variants, a novel form of rat brain PLC P4 has been
recently isolated by Kim et al. (1998). This variant, named PLC P4b, has a
shorter C-terminal tail compared with the previously identified enzyme (PLC
P4a) (Kim et al., 1993; Ferreira et al., 1993; Lee et al., 1993). In PLC p4b,
the C-terminal 162 amino acids of PLC p4a are replaced by 10 distinct
amino acids. The comparison of the cDNA sequences of PLC p4a and PLC
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P4b predicts that they may be generated by alternative processing of the 
mRNA.
In contrast to PLC P4a, which is a membrane-associated enzyme activated by 
G t t q ,  PLC P4b is cytosolic and insensitive to G Œ q  stimulation. Therefore it 
seems that the carboxyl-terminal 162 amino acids in PLC P4a are necessary 
for the association with the particulate fraction and activation by G .
As Banno et al.(1994) had reported that a carboxyl-terminal truncated form 
of PLC pS generated by calpain cleavage can be activated to a greater extent 
by brain G protein py subunits than the intact PLC P3, it was suggested that 
the carboxyl-terminal region of PLC P3 may inhibit its activation by G 
protein py subunits. Although it has been known that PLC P4a cannot be 
activated by G protein py subunits in vivo and in vitro, Kim et al. raised the 
question of whether G protein regulation of the 116-KDa PLC P4b might 
occur by Py subunits. However they found that PLC P4b, having a short 
carboxyl-terminal tail, is nevertheless unresponsive to regulation by G 
protein Py subunits. Therefore these results suggested that PLC P4 does not 
have the sequence motif necessary to be activated by G protein Py subunits. 
Expression of PLC P4 in the retina and its clear homology to norpA sequence 
implies that PLC p4 may play a role in the mammalian visual process. A 
mouse line that lacked PLC P4 was generated by Jiang et al. (1996) and the 
physiological significance of PLC p4 in murine visual function was
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Fig.5 Domain structure of PLC P4 isoforms.
The rat brain (RPLCP4; GenBank™/EMBL Data Bank accession number
L15556), bovine retina (BPLCP4; GenBank™/EMBL Data Bank accession
numbers L13935, L13936, L13937, L13938), and human retina (HPLCP4; 
GenBank™/EMBL Data Bank accession number L41349) isoforms are 
schematically represented by boxes. The isoforms are aligned according to 
the relative positions of alternatively spliced exons P3 and P4. Conserved X 
and Y boxes are lightly shaded. To the right of the dotted line, sequences are 
homologous in all three isoforms. To the left of the dotted line, sequences in 
the retina isoforms (pl domain) are unique and specific. The P3 domain is 
contained in rat brain, human retina, and two of four bovine retina variants. 
The P4 domain has been identified only in bovine retina.
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investigated. Behavioral tests using a shuttle box demonstrated that the mice 
lacking PLC P4 were impaired in their visual processing abilities, whereas 
they showed no deficit in their auditory abilities. In addition, the PLC p4-null 
mice showed 4-fold reduction in the maximal amplitude of the rod a- and b- 
wave components of their electroretinograms relative to their littermate 
controls. However, recording from single rod photoreceptors did not reveal 
any significant differences between the PLC p4-null and wild-type 
littermates, nor were there any apparent differences in retinas examined with 
light microscopy. These results suggest that the effect of PLC P4 deficiency 
on the rod signalling pathway occurs at some stage after the initial 
phototransduction cascade and may require cell-cell interactions between 
rods and other retinal cells. More recently, Kim et al. (1997) have reported 
that PLC P4-/- mice are ataxic. They were hypokinetic and showed a 
waddling gait, with the rear body swinging left-right. In the brain, expression 
of PLC P4 is highest in the cerebellum and is almost negligible in the 
cerebral cortex and hippocampus (Tanaka and Kondo, 1994). Histological 
analysis of PLC p4-/- mice revealed that the development of the cerebellum 
was retarded, but apparently normal except for a slight reduction in size. 
Dendrogenesis of Purkinje cells examined by anti-calbindin staining and the 
number of synapses on dendritic spines, as examined by transmission 
electron microscopy, were also normal in the cerebellum of PLC (34-/- mice, 
suggesting that the motor defect in these mice was not due to any grossly
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abnormal development of the cerebellum. To determine the molecular basis 
of the phenotypic defects of the mutant mice, the authors selected three 
agonists on the basis of the known expression patterns of corresponding 
PLC-coupled receptors: carbachol (CCh), a non-selective agonist on 
muscarinic acetylcholine receptors (mAChR), 1-amino-1,3-
cyclopentanedicarboxylicacid (ACPD), a non-selective agonist on 
metabotropic glutamate receptors (mGluR) and l-(3-chlorophenyl)piperazine 
(mCPP), a non-selective agonist on serotonin (5-HT) type-2 receptors. In the 
cerebellum of PLC P4-/- mice there is less phosphoinositide hydrolysis 
induced by CCh or ACPD whereas PLC p l-/- mice show a preferential 
attenuation of CCh-induced phosphoinositide hydrolysis in the hippocampus. 
Thus, in cerebellum, PLC P4 appears to be the transducer of signals mediated 
by mGluR, whereas PLC p l and PLC P4 both transduce mAChR-mediated 
signals. As PLC P4 is enriched in Purkinje cells, the ataxia phenotype of PLC 
P4-/- mice may, at least in part, be the result of an impaired mGluR signal- 
transduction pathway in Purkinje cells. This is supported by the findings that 
mGluRl is expressed predominantly in cerebellar Purkinje cells (Masu et al., 
1991) and that mGluRl knockout mice show ataxia (Aiba et al. 1994). Thus, 
PLC P4 appears to be essential for transducing mGluRl-mediated signals in 
cerebellum, which accounts for the defect seen in PLC P4-/- mice. Activation 
of the type-1 metabotropic glutamate receptor (mGluRl) signaling pathway 
in the cerebellum involves activation of phospholipase C (PLC) and protein
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kinase C (PKC) for the induction of cerebellar long term depression (LTD). 
In PLC P4-/- mice, recent work has shown that expression of total PLC P, the 
mGluRl-mediated Ca^^ response, and LTD induction are greatly reduced in 
rostral cerebellum. Furthermore, during LTD induction, both PKCa and 
PKCpi have been found to be translocated to the plasma membrane. These 
results suggest that mGluRl-mediated activation of PLC P4 in rostral 
cerebellar Purkinjie cells induces LTD via PKCa and/or PKCpi (Hirono et 
al., 2001).
NorpA
The norpA gene encodes at least four transcripts: a 7.5kb transcript that is 
expressed in eye and 6.5-, 5.5-, and 5.0-kb transcripts that are expressed in 
adult body or early stages of development. Antiserum generated against the 
major gene product of norpA recognizes a 130-kDa protein that is abundant 
in eyes but severely reduced or absent in norpA mutants; it also recognizes a 
130-kDa protein in adult legs, thorax, and male abdomen, but not female 
abdomen. Furthermore, immunohistochemical staining of tissue sections with 
the norpA antiserum shows that the norpA protein is abundant in the retina 
and ocelli and is present to a lesser extent in the brain and thoracic nervous 
system (Zhu, 1993). This tissue distribution of norpA transcripts is identical 
to the distribution of transcripts from a Drosophila Go alpha-subunit gene 
(Shortridge, 1991).
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The norpA gene of Drosophila melanogaster encodes a phosphatidylinositol- 
specific phospholipase C that is essential for phototransduction, as its 
mutants have long been known to be deficient in light-induced electrical 
responses in the compound eye (Pak et al., 1970) and ocellus (Hotta and 
Benzer, 1970) with strong mutations rendering the fly blind. Drosophila 
photoreceptor neurons show a high degree of architectural organization, with 
most of the molecules involved in phototransduction localized to the 
rhabdomeres. In rhabdomeres, photoconversion of rhodopsin to 
metarhodopsin activates a Gq protein a-subunit (GqŒ), which in turn 
activates PLC P, leading to depolarization via gating of two cation channels, 
the transient receptor potential (TRP) and TRPL light-activated channels. 
Following termination of the stimulus, calcium-dependent regulatory 
processes including activation of protein kinase C (eye PKC), mediate 
deactivation of the light response. NORPA protein has been shown to be an 
integral part of a signal transduction complex associated with the rhabdomere 
membrane. This signal transduction complex is organized by an adapter 
protein, INAD (inactivation no-after potential D), which binds and clusters 
protein kinase C, the TRP calcium channel, and NORPA (PLCP) in the 
visual cascade. The carboxyl terminal tail of NORPA interacts with the 
sequence spanning the last three PDZ domains of INAD (Shieh et al., 1997). 
Null INAD mutants have a dramatically reorganized subcellular distribution 
of signalling molecules, and a total loss of transduction complexes (Tsunoda
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et al., 1997). Also, mutants defective in a single PDZ domain of INAD 
produce signalling complexes that lack the target protein and display 
corresponding defects in their physiology. Thus, the interaction of NORPA 
with INAD is essential for a rapid and controlled visual response.
The vertebrate retinal PLC, PLC p4, shares a greater similarity with NORPA 
than with other PLC p isotypes (Kim et al., 1993; Lee et al., 1993). This 
suggests that regulation of PLC P4-mediated signal transduction may be 
similar to the NORPA-mediated mechanism in Drosophila. PLC p4 is not 
involved in the rhodopsin initiated visual response in mice. However, PLC 
P4 is expressed in photoreceptor, bipolar, horizontal, and ganglion cells of 
the bovine retina, in the cerebellum and in neurons connecting the retina to 
the cerebellum in the human and mouse brain (Kim et al., 1993; Ferreira et 
al., 1994; Alvarez et al., 1995). The findings of Jang et al., (1996) and of Kim 
et al. (1997) by generating null PLC p4 mice indicate that PLC P4-mediated 
signalling is essential for processing of visual information required for 
learning from visual cues and coordination of ongoing movement. By 
analogy with NORPA-mediated signalling pathway, it is likely that the 
carboxyl terminal tail of PLC P4a interacts with an INAD-like adapter 
protein for inclusion in a membrane-associated complex, as it contains a PDZ 
binding consensus motif. It is interesting to note that a human INAD-like 
protein (hINADL) has been identified which is expressed in the cerebellum
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(Philipp et al., 1997). Further analysis will be necessary to determine if 
indeed PLC P4a mediates a signalling cascade similar to that of NORPA.
MECHANISMS OF REGULATION OF PLC p B Y G PROTEIN 
SUBUNITS
It is well established that both PTX-insensitive and PTX-sensitive G proteins 
couple receptors to PLC p (Fig.4). The PTX-insensitive pathway that 
stimulates PLC P is mediated by the Gq family. This pathway is activated by 
various receptors, including bradykinin, histamine, angiotensin. M l 
muscarinic and a l  adrenergic receptors (Gutowski et al., 1991; Berstein et 
al., 1992b; Wu et al., 1992b). Several studies have shown that the a  subunit 
of Gq proteins can directly stimulate PLC P isozymes (Taylor et al., 1991). 
Another group of agonists such as acetylcholine (binding to M2 and M4 
muscarinic receptors), catecholamines (binding to a2  adrenergic receptors), 
interleukin 8, thrombin, eicosanoids (prostaglandin PGE2), the leukotrienes 
LTC4 and LTD4 and thromboxane TXA2, all activate PLC p via pertussis 
toxin-sensitive Gi/o proteins (DelPacqua et al.l993; Wu et al., 1993a). This 
activation is mediated by G Py rather than G a  subunit (Camps et al., 1992; 
Katz et al., 1992).
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All the PLC P enzymes, with the exception of PLC p4b (Kim et al., 1998), 
can be activated by the a subunits of the Gq class (Smrcka et al., 1991; 
Taylor et al., 1991; Wu et al., 1992a; Jhon et al., 1993), but there is evidence 
that they differ in their sensitivity to the various a subunits. For instance, the 
p i and P3 isozymes are activated to a similar extent by a a and a
though the p2 isozyme appears less sensitive (Smrcka and Stemweis, 1993; 
Kozasa et al., 1993; Hepler et al., 1993). PLC P4 can be activated by all the a  
subunits of the Gq family, though and are the most efficient (Jiang et
al., 1994).
There has been some definition of the domains in PLC P that are involved in 
interaction with (Xq (Fig.3). Wu et al (1993b) coexpressed various mutant 
forms of PLC p i with Œq in COST cells and found that the region required 
for ttq activation was localized to residues 1030-1142 of the C-terminal 
portion of the molecule (Wu et al., 1993b). These results were supported by 
the observation that two peptides from the interaction region inhibit 
activation of the enzyme by oCq. The conclusion that sequences of the C- 
terminal region of PLC p l are involved in its interaction with Œq is reinforced 
by the analysis of the ability of proteolyzed forms of the phospholipase to 
interact with the a  subunit (Park et al., 1993). These studies localized the 
activation site between residues 880 and 1130. Additionally, Blank et al. 
(1993) found that a truncated form of PLC P3 that lacked most of the C-
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terminus was completely unresponsive to similarly to PLC P4b (Kim et 
al., 1998).
As mentioned above, it is well known that PLC is also regulated by PTX- 
sensitive Gyo proteins (Verghese et al., 1985; Cockcroft and Gomperts, 
1985). However, efforts to demonstrate stimulation of PLC isozymes by the 
a  subunits of these G proteins proved unsuccessful. Substantial evidence 
indicates that the Py subunits of Gi/o proteins are responsible for PLC 
activation. Biochemical studies of Camps et al. (1992) reported that Py 
subunits from transducin or brain can activate PLC from HL60 cells, human 
promyelocytes and neutrophils. Blank et al. (1992) independently purified a 
G protein Py complex that activated PLC from liver and brain. In addition, 
studies with turkey erythrocyte PLC (Boyer et al., 1992) revealed that low 
concentrations of Py-subunits can reverse the stimulatory effect of activated 
a n , whereas higher concentrations of the subunits are stimulatory. These 
results were substantiated by experiments that showed PLC P2 activation by 
py subunits in transfected cells (Camps et al., 1992; Katz et al., 1992). 
Consistent with these findings, Koch et al. (1994) observed that expression 
of the C-terminus of PARK (which binds to py subunits), in COST cells, 
blocked inositol phosphate production stimulated by a2  adrenergic and M2 
muscarinic receptors, which couple to Q , but did not affect the response to 
a l  adrenergic and M l muscarinic receptors, which couple to Gq. Several
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studies have shown that P2 and, possibly, P3, but not p i and P4, isozymes 
are targets of py-subunits. Camps et al. (1992) expressed the p i and P2 
isozymes in COSl cells and demonstrated that the P2 isozyme was more 
responsive to Gt Py subunits than PLC p i. Katz et al. (1992) coexpressed the 
p i and P2 isozymes together with different G protein P and y subunits in 
COST cells and examined the inositol phosphate responses to carbachol. 
Transfection of Pp and yp or y2-subunits together with PLC P2, but not PLC 
Pl, resulted in a marked response. In “in vitro” studies, PLC P2 is well 
activated by Py subunits, while PLC p l is only weakly responsive (Camps et 
al., 1992). Other reports demonstrated that, in lipid vesicles, purified PLC p3 
is much more responsive to Py subunits than PLC P2 or PLC p i (Park et al. 
1993). This effect of Py remains however to be further characterized, as 
expression of PLC P3 in COST cells showed no response to Py (Jiang et al., 
1996b); there are probably other factors, such as substrate 
compartmentalization, modification, and membrane interaction and the 
involvement of accessory proteins, which may mediate specificity in the 
cellular system. Thus, the role of Py in regulation of PLC p3 remains unclear. 
However, activation of PLC p3 by G Py may occur in vivo in cells where the 
expression levels of PLC P3 are higher than those of the recombinant in 
COST cells or where the subcellular localization of PLC P3 or production of 
accessory proteins is differently regulated. Although the G proteins that
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Fig. 6.GPCR-mediated activation of PLC-P isozymes. An agonist-occupied GPCR 
induces the exchange of GDP for GTP on the G protein a  subunit and the subsequent 
dissociation of this subunit from the membrane-associated G^y dimer. In contrast to the 
depiction in the middle portion of the figure, the dissociated Ga subunits remain localized 
at the membrane as e result of their covalent lipid modification.The GTP-bound oc subunits 
of the Gq subfamily mediate the targeting of PLC-|3 to the membrane and activate it as a 
result of interaction with the C2 domain and downstream COOH-terminal region of the 
enzyme (right). The membrane localization of PLC-p isozymes might be further promoted 
by interaction of the PH domain with PtdIns(3)P (PI3P) generated in response to ligation of 
the GPCR. Hydrolysis of GTP to GDP at the active site of Ga subunits by their intrinsic 
GTPase activity results in the reassociation of a  with the py subunits and reformation of 
the inactive heterotrimer. RGS proteins and the COOH-terminal region of PLC-P stimulate 
the GTPase activity of Gqa, leading to inhibition of the GPCR signal. The membrane- 
anchored GPy dimer also recruits PLC-P by interacting with the PH and Y domains 
(interaction with the Y domain is not shown) (left); this recruitment is also aided by the 
presence of PtdIns(3)P in the membrane. The EF-hand domain of PLC-p is not shown 
(Rhee, 2001).
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release the activating py subunits are in most cases sensitive to PTX, they are 
not precisely identified. Different combinations of P and y subunits have 
been tested for their capacity to activate PLC p (Pronin and Gautam, 1992). 
In one study, the functional dimers were Pj complexed with y%^ y2, Ys, Ys Y?» 
and P2 complexed with Yj, Y3, Y, and Y,; the less effective was Pi Yi (Pronin 
and Gautam, 1992).
There is some evidence that agonists to receptors coupled to Gi/o proteins can 
not only stimulate, but also inhibit phospholipase C (Delahunty et al., 1988; 
Enjalbert et al., 1990). While the PTX-sensitive stimulatory pathway has 
been characterized in considerable detail, the mechanism(s) and subunit(s) 
involved in Gi/o-mediated PLC inhibition remain to be established. Activation 
of dopaminergic D2 receptors on lactotrophs, which couple to both G^  and Gq 
(Liu et al., 1994; Watts et al., 1998), cause a PTX-sensitive inhibition of the 
stimulated inositol phosphate production induced by TRH (Enjalbert et al., 
1986; Vallar et al., 1988; Enj albert et al., 1990). Vallar et al. (1988) showed 
that dopamine progressively inhibits late inositol phosphate production 
induced by TRH. This inhibition appears to be a consequence of the 
previously demonstrated inhibition by dopamine of the prolonged cytosolic 
free Ca^^ concentration increase induced by TRH via the activation of 
voltage-gated Ca^ "^  channels (Malgaroli et al., 1987). Enjalbert et al. (1990) 
found that, in addition to the late Ca^'^-dependent component of the inhibitory
effect of dopamine, there is also a rapid component, which might be directly
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mediated by G protein subunits. In parallel, Bizzarri et al. (1990) showed that 
the muscarinic agonist carbachol inhibits phospholipase C via Gj/o proteins in 
both intact and permeabilized rat thyroid FRTL5 cells. Subsequently, Martin 
et al. (1995) have found that, in coated vesicles from bovine brain, 
metabotropic glutamate receptor agonists inhibit guanine nucleotide- 
stimulated phospholipase C activity through pertussis toxin-sensitive G 
proteins. Interestingly, dual regulation of PLC activity by guanine 
nucleotides has been demonstrated in rat cerebral cortical membranes 
(Litosch, 1989) and mast cells (Avidor et al., 1990). Inhibition of PLC 
activity occurred with nanomolar guanine nucleotide concentrations, whereas 
stimulation ensued with micromolar concentrations of guanine nucleotides. 
Additional work showed that solubilized bovine brain membrane 
preparations retain G protein-dependent inhibition of PLC activity which 
occurs through a rapid but transient mechanism and results in a decrease in 
the Ca^ "** sensitivity of PLC (Litosch, 1993). Taken together these data 
suggest the possibility that an inhibitory Gi/o protein subunit might directly 
mediate receptor-induced inhibition of phospholipase C.
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SPECIFIC BACKGROUND
The work presented in this thesis has investigated the possible role of the a  
subunits of the Gj/o proteins in inhibition of phospholipase C activation by 
stimulatory receptors. The experimental approach chosen has been the 
expression of mutationally activated G and/or G subunits in Ltk" and 
COST cells.
In the course of these studies, it has been found that in both cell types G 
protein-mediated stimulation of phosphoinositide hydrolysis involves a novel 
isoform of PLC P4 (PLC p4c). The characterization of this PLC P4 variant is 
also presented.
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REGULATION OF POLYPHOSPHOINOSITIDE HYDROLYSIS BY 
Gao PROTEIN IN Ltk FIBROBLASTS 
Expression of GŒq in Ltk clones
The mechanisms of regulation of PLC by Gi/o protein a  subunits have been 
investigated in mouse Ltk' (thymidine kinase') fibroblasts, a cell line already 
characterized in our lab for stable transfection experiments. The latter cells 
were stably transfected with the wild-type (WT) or a constitutively active 
mutant (Q205L) form of the Œq subunit. The Q205L substitution in ao, 
consistent with the effects of corresponding activating mutations in as and 
ai2, which inhibit the GTPase activity o f the proteins (Landis et al., 1989; 
Freissmuth and Gilman, 1989; Wong et al., 1991), creates a mutant subunit 
that constitutively activates downstream effectors (Kroll et al., 1992; Wong et 
al., 1992). As control, I used Ltk' cells that were transfected with cDNAs 
encoding Gag-WT and Gag-Q205L but failed to express the corresponding 
proteins. This effect was probably due to the integration of the transgenes in 
transcriptionally inactive regions of the genome or to silencing processes. 
Immunoblot analysis of the particulate fractions of Ltk' clones confirmed the 
overexpression of the transfected subunits in the positive clones (lanes 3 and 
5, Fig.l) when compared with the signal corresponding to the endogenous 
level of Gagin the control clones (lanes 1, Fig.l). In the same positive clones, 
pretreatment of the cells with Na-butyrate (lanes 4 and 6, Fig.l), enhanced 
the overexpression of Gag-WT and Gag-Q205L with respect to non treated
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clones, while it did not affect the endogenous level of GOg (lanes 2, Fig.l). 
The identity of Gag-WT and Gag-Q205L was confirmed by diagnostic 
digestion with the restriction enzyme Hae III. Gag cDNA containing the 
Q205L mutation lacks this restriction site (data not shown).
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Fig.l. Analysis of the expression of Gag in Ltk clones.
Membrane proteins (100 |ig) from three representative Ltk' clones transfected 
with vector or wild type (WT) or mutant (Q205L) Gag were separated on a 
10% SDS polyacrylamide gel and detected by immunoblotting with a Gttg- 
specific antibody as described in MATERIALS AND METHODS. Cells were 
mantained in normal medium (lanes 1-3-5) or exposed to Na-butyrate (lanes 
2-4-6) as described in MATERIALS AND METHODS. The relative 
molecular mass marker (in kDa) is shovm to the left. Data are representative 
of three similar experiments.
74
Effect of Gao on inositol phosphate production in Ltk' cells
To investigate the effects of Œg on PLC activity, I stimulated inositol 
phosphate production by agonist stimulation of both PTX-insensitive (ATP) 
and PTX-sensitive (LPA) G protein-coupled receptors. As expected, 
preliminary experiments in clones of Ltk" cells transfected with the cDNAs of 
wild type or mutant Gao but not expressing the corresponding proteins 
showed that ATP-activated inositol phosphate production was insensitive to 
PTX, while the LPA response was inhibited by approximately 70% by PTX 
(Fig. 2A). Fig. 2B shows the results of a set of experiments in stably 
transfected Ltk" clones, expressing the wild-type or the constitutively active 
mutant form of ao- In control clones, IP release was increased 4-5 fold by 
ATP and 8-11 fold by LPA compared with non stimulated cells. Transfection 
with Gao-Q205L did not affect the basal inositol phosphate production, but 
led to a 25% reduced activation of PLC stimulated by ATP and to a 30% 
reduced activation o f PLC stimulated by LPA compared with control cells. 
Expression of Gao-WT failed to alter basal and ATP- or LPA-stimulated 
inositol phosphate accumulation. From this preliminary result, I could 
hypothesize a possible inhibitory role of Gao-Q205L in the regulation o f PLC 
activity, directly or by the involvement of an inhibitory component. Finally, I 
could not exclude that the observed effect was due to aspecific compensatory 
mechanisms resulting from the prolonged expression o f the mutant protein.
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To test at least partially this hypothesis, I tried to reproduce the reduction of 
agonist-stimulated activity of PLC upon a short-time enhancement of the 
overexpression of the transfected subunits, by treating the cells with Na- 
butyrate for 48 hours before the PI assay.
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Fig. 2A. Effect of Ga  ^on inositol phosphate production in Ltk cells.
Clones of Ltk’ cells transfected with the cDNAs of wild type or mutant Gao 
but not expressing the corresponding proteins were stimulated with 100 pM 
ATP or LPA for 30 min and treated or not with PTX. Inositol phosphate 
production was measured as described in MATERIALS AND METHODS. 
Data are means ± S.E. o f the results obtained with three clones, each assayed 
in at least two experiments in triplicate determinations.
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Fig. 2B. Effect of Ga  ^on inositol phosphate production in Ltk cells.
Clones of Ltk’ cells expressing wild type (WT) or mutant (QL) Gao and 
clones transfected with the same cDNAs but not expressing the 
corresponding proteins (Control-WT and -QL) were stimulated with 100 pM 
ATP or LPA for 30 min. Inositol phosphate production was measured as 
described in MATERIALS AND METHODS. Data are given as ratios of the 
increase in IP production induced by ATP or LPA over the total of inositol 
and inositol phosphate products and are means ± S.E. of two experiments 
carried out in triplicate.
cco QL *(ATP)/ CQL* (ATP) data differences are statistically significant (T- 
test: p<0.1; n=9)
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Effect of Gtto on inositol phosphate production in Ltk cells treated with 
Na-butyrate
Na-butyrate is involved in the accumulation of multiacetylated forms of 
histones H3 and H4 which results in an alteration of chromatine structure at 
the nucleosomal level and in the selective DNAse I sensitivity of 
transcriptionally active DNA sequences in different cell types (Vidali et ah, 
1978; Gavazzo et ah, 1997). Since exposure of transfected cells to Na- 
butyrate can increase the expression o f transfected proteins experiments 
similar to those described in Fig.2 were performed in cells pretreated with 
this agent. Western Blot analysis showed that Na-butyrate causes a marked 
increase in the expression of both wild-type and mutant Gao subunits (Fig.l). 
As shown in Fig.3, Na-butyrate, by itself decreased basal (from 5% to 2%, at 
least two-fold) as well as ATP- (from 27% to 17%, almost two-fold) or LPA- 
(from 58% to 42%) stimulated IP production in control cells compared with 
non-treated cells (Table 3). After treatment with Na-butyrate, the clones 
expressing Gao-WT gave results entirely comparable to those observed in 
control clones. In contrast, in Gao-Q205L-transfected clones, Na-butyrate 
induced an approximately two-fold enhancement of the inhibition of ATP- 
and LPA-stimulation.
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Stimulus Basal ATP LPA
N a-butyrate - + - + - +
Control-wt 4 ^ 6
±0.59
1.96
±0.36
27.02 
±1.9 
(5 fold)
15.73 
±1.73 
(8  fold)
58.1
±1.89
(1 2
fold)
42.29 
±3.6 
(2 2  fold)
Control-QL
±1.08
245
±0.19
26.48 
± 1 .6  
(4 fold)
□
15.24 
±2.78 
(5 fold)
6 6 .2  
±2.16 
(8  fold)
37.11 
±1.96 
(13 fold)
Gtto wt 5.13
±0 .6
1.14
±0.06
24.05 
±1.13 
(5 fold)
16.88 
±0.98 
(15 fold)
59.46 
±2 .1  
(1 2  fold)
36.55 
±0.95 
(32 fold)
Gao QL 6.75
±0.65
1.47
±0.08
2 0 .0 1  
± 1.1 
(3 fold)
7.14 
±1.47 
(5 fold)
40.81 
±1.51 
(6  fold)
16.55 
±0.49 
(1 1  fold)
Table 1. All data are presented as the ratio of [^H]IP divided by [^H]
inositol plus [ H] IP xlOOO.
Fig. 3. Effect of Ga« on inositol phosphate production in  L tk  cells treated 
with Na-butyrate.
The indicated clones of Ltk' cells were pretreated with Na-butyrate as 
described under MATERIALS AND METHODS. Cell stimulation and 
measurement of inositol phosphate production were as described in the 
legend to Fig. 2. Data are means ± S.E. of the results obtained with three 
clones, each assayed in at least two experiments in triplicate determinations, 
tto QL *(ATPy CQL *(ATP) data differences are statistically significant (T- 
test: p<0.1; n=9)
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Effect of Gttii on inositol phosphate production in Ltk cells
To test if the effect on PLC activity observed in Gao-Q205L-transfected 
clones was specifically triggered by the expression of mutant Gao and not of 
any other mutant G a subunits, parallel experiments were performed in Ltk" 
clones expressing the wild-type and the active mutant form of Gan. In 
contrast to the results obtained in cells expressing Gao, ATP- and LPA- 
stimulated inositol phosphate accumulation was not affected by expression of 
either G a^-W T or Gan-Q204L (Fig.4).
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Fig. 4. Effect of Ga^ on inositol phosphate production in Ltk cells.
Clones of Ltk’ cells expressing wild type (WT) or mutant (QL) Gaü or 
transfected with the latter cDNA but not expressing the corresponding 
protein were stimulated and assayed for inositol phosphate production as 
described in the legend to Fig.2. Data are means ± S.E. of two experiments 
carried out in triplicate on three representative clones. Similar data were 
obtained with at least an additional independent clone.
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Effects of Gtto and Ga;i on cAMP levels in Ltk cells
To investigate whether in Ltk' cells expression of mutant ao controls other 
effector pathways which could account for PLC inhibition, I analyzed cAMP 
production. It is well established that Gao protein is able to inhibit adenylyl 
cyclase I, which, although expressed mainly in brain, is present at lower 
amounts also in other cell types (Wu et al., 1992; Law et al., 1993). For these 
experiments, Ltk' clones were stimulated with forskolin, which directly 
activates the catalytic subunit of adenylyl cyclase (Premont et al., 1996). In 
cells expressing Gao-Q205L, forskolin stimulation o f cAMP levels was 
comparable to that detected in control and Gao-WT clones (Fig. 5). Parallel 
experiments were performed by using clones transfected with Ga^, which 
regulates adenylyl cyclase negatively (Bimbaumer, 1990). As expected, 
expression of a constitutively activated au (-QL) decreased cAMP levels. 
These results exclude the possibility that the effect o f Gao on inositol 
phosphate production is due to inhibition of intracellular cAMP 
accumulation.
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Fig. 5. Effects of Gao and Ga.i on cAMP levels in Ltk" cells.
The indicated clones of Ltk’ cells were stimulated with 20 |iM Forskolin for 
20 min and cAMP levels were assayed as described in MATERIALS AND 
METHODS. Results are means ± S.E. of two experiments carried out in 
triplicate on representative clones. Similar results were obtained with at least 
an additional independent clone.
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Effect of GoCo on IP3 production in Ltk cells incubated in Ca^-free
medium
It is well established that PLC activity is dependent on intracellular [Ca^^]i 
(Exton, 1996). In addition, it has been reported that receptor-mediated PLC 
inhibition is, at least partially, dependent on the inhibition of Ca^ "^  influx 
(Vallar et al., 1988). However, the experiment illustrated in Fig.6  shows that 
removal of extracellular Ca^^ is without effect on the ability of Gao-Q205L to 
inhibit PLC activity stimulated by ATP or LPA. Moreover, in the presence of 
the Ca^^ ionophore ionomycin, which markedly augments [Ca^^ ] i ,  the basal 
levels of inositol phosphates as well as the levels induced by the ATP or LPA 
stimuli and the Gao-Q205L inhibition remained unchanged (data not shown). 
This is in agreement with the observation by Bizzarri et al. (1990) that, in 
FRTL5, the PLC activity is not stimulated by Ca^ .^
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Ca^^free medium
o
[i?l BASAL 
ATP 
0  LPAI
II
I
I
Ga„-QLGa_-WTControl
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Stimulus
Ca^ ^
Basal
+
A T P
+
LPA
+
Control 1 0 .2 1
±0 .0 0 1
11.3
±1.04
19.27
±1.09
26.25
±2.52
60.54
±2.54
65.92
±1.75
Gtto wt 1 1 .2
±0 .0 0 1
11.57
±0.9
19.25
±0.43
25.56
±0.73
57.74
±2.18
59.3
± 1 .6
Gtto QL 8T8
±0 .0 0 2
10.95
±0.72
17.09
±0.72
19.52
± 1 .2 0
36.43
±1.41
39.32
±1.32
Table 2. All data are presented as the ratio of [^H]IP divided by [^H]
inositol plus [ H] IP xlOOOO.
Fig. 6 . Effect of Gtto on IP3  production in Ltk cells incubated in Ca^^-free 
medium.
The indicated clones of Ltk" cells were stimulated with 100 juM ATP and 
LPA after incubation in Ca^^-firee medium as described in MATERIALS 
AND METHODS. IP3 was measured as described under MATERIALS AND 
METHODS. Data given are means ± S.E. of the results obtained with two 
clones, each assayed in at least two independent experiments, carried out in 
triplicate.
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Effect of Gtto on inositol phosphate production in C0S7 cells
To study the possible regulation of PLC activity by Gao, 1 tried to reproduce
in transiently transfected Ltk" cells the effect observed in Ltk" clones. The
advantage o f using this experimental approach is the possibility o f
cotransfecting multiple proteins in the same cells so that a signalling cascade
can be reconstituted and analyzed in vivo. Unfortunately, the efficiency o f
transient transfection of Ltk" cells was too low to give reproducible results. I
therefore tried to reconstitute the Gao signalling pathway in monkey kidney
fibroblast COS7 cells, which are widely used for transient transfection
experiments (Conklin et al., 1992; Wu et al., 1992; Slepak et al., 1995). I first
verified that Gao-Q205L is also able to inhibit receptor-mediated stimulation
of PLC in this system. To this aim, I measured inositol phosphate production
after cotransfection of the Gq-coupled a l  adrenergic receptor together with
Gao-WT or Gao-Q205L and stimulation with phenylephrine. Transfection
with the a l  adrenergic receptor alone, allowed phenylephrine-mediated
generation o f inositol phosphate release (Fig.7), but cotransfection with Gao-
Q205L did not suppress this response (variations in inositol phosphate
production are not significantly different). It should be noted that in these
experiments Gao-WT slightly inhibited the phenylephrine response (p<0.05
T-test). A marked inhibition could be observed by increasing the Gao-WT
cDNA concentration used for transfection (data not shown). A feasible
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mechanism to rationalize the attenuation of the Gaq-mediated activation of 
PLC by cotransfected Gao-WT is the competition between Gao and the 
endogenous Gaq subunits for the Py complexes, which are necessary for the 
G protein coupling with receptors (Slepak et al., 1995). Thus, transfected 
wild type Gao would decrease the formation of heterotrimers containing Gaq 
subunits available for a l  adrenergic receptor-mediated PLC activation. In 
contrast to Gao-WT, Gao-QL does, not exert the same effect because unable 
to efficiently associate to py complexes.
Since the effect of the constitutively active form of Gao on PLC activation in
Ltk" clones was not reproduced in transient transfection experiments in C0S7
cells, I cannot exclude that the results in Ltk" clones were due to redundant
effects resulting fi*om the prolonged expression of the mutant protein, even if
a short pretreatment o f the cells with Na-butyrate enhanced the effect. A
strong disregulation of the system could also result from the use of pcDNA I
expression vector, which contains SV40 Ori site, for transient transfection
experiments in C0S7 cells, a cell line transformed by SV40.
Furthermore, the lack o f induction of IP production by exogenous PLC P3
and - p4 in control could be explained by the lack of Gaq which was not
overexpressed and could represent the limiting factor in this experiment.
Alternatively, Gao could inhibit PLC through intermediate components not
available in C0S7 line. Enzymes involved in the transduction cascade such
as cAMP-dependent protein kinase A and protein kinase C or PI3-kinase
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could play a role in the inhibition of PLC activity. The data obtained in the 
presence of forskolin do not support a possible role for protein kinase A, 
since it is shown that Gao-Q205L did not decrease intracellular cAMP levels. 
The possible role of protein kinase C should be analyzed by using its specific 
activator phorbol myristate acetate (PMA) or the inhibitor GF 109203X, 
while the involvement of PI3-kinase could be tested by using inhibitors like 
Wortmannin or more specifically LY 294002. More likely, I propose that Gao 
could regulate a specific PLC enzyme expressed in Ltk" cells and not in 
C0S7 cells. Thus I checked for the PLC isozymes pattern expressed in Ltk" 
or in C0S7 cells.
92
«0
s  60
-  40
C
— 20
PLC
EU Basai
0  Phenylephrine
[33 [34c [33 [34c [33 [34c
Control Goo-WT Goo -Q205L
Fig. 7. Effect of Ga„ on inositol phosphate production in COS7 cells.
Cells were cotransfected with 3 pg of a l  adrenergic receptor and/or 5 pg of 
Gao-WT or -Q205L cDNA and/or 10 pg of PLC P3 or PLC p4c cDNA as 
described under MATERIALS AND METHODS. Cells were stimulated with 
2 pM Phenylephrine for 30 min. Inositol phosphate production was measured 
as described in MATERIALS AND METHODS. Data are means + S.E. of the 
results obtained in at least two experiments in triplicate determinations.
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Expression of PLC pi, PLC P2, PLC p3, and PLC P4 mRNA in Ltk" and
COS7 cells
The failure to detect effects of activated Gao in C0S7 cells suggested, among
the hypothesis explained in the former paragraph, the possibility that Gao
regulates a specific PLC p isozyme, expressed in Ltk" cells and not or, at least
not sufficiently, in C0S7 cells. To test this idea, I analyzed the PLC P
isozymes present in Ltk" and C0S7 cells (Fig.8 ) using RT-PCR with PLC p
subtype-specific couples of oligonucleotides mapping in the C-terminal
region and perfectly conserved among the species. C0S7 cells are monkey
cells and very little sequence information is available in that species; so, a
negative result may be due to the fact that primers fail to amplify in that
species. For this reason each negative result was confirmed by performing
RT-PCR reaction also at very low stringency conditions (data not shown). As
positive controls, brain was used in the screening for PLC p i, p3, p4 and
HL60 cells for PLC P2. The identity of all the amplification fi*agments was
controlled by diagnostic digestions (data not shown). RT-PCR for PLC pi
performed by using primers PB IF and PBIR gave the expected band of
915bp in brain, but not in Ltk" or in C0S7 cells (Fig. 8 ). RT-PCR for PLC P2
with primers PB2/3F and PB2R is shown in Panel B: the band of 721 bp
corresponding to PLC p i, present in HL60 cells, appears neither in Ltk" nor
in C0S7 cells. Two additional bands were detected in HL60 cells. Diagnostic
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digestion revealed that these fragments were consistent with three putative 
variants o f PLC p2. RT-PCR for PLC P2 with different couples of 
oligonucleotides produced the same results (data not shown). Panel C shows 
the results of screening experiments for PLC p3 carried out by using primers 
PB2/3F and PB3R: the same expected band of 1743bp is amplified in brain 
as well as in Ltk' cells, but not in the C0S7 line. Finally, Panel D shows the 
RT-PCR for PLC P4 obtained by using primers PB4F and PB4R. In the brain, 
two bands are detectable: the expected fragment of 477bp and another 
product of about 500bp present also in Ltk" and C0S7 cells. As will be 
described in detail below, the RT-PCR product in Ltk" and C0S7 cells 
corresponds to a novel PLC p4 variant termed PLC P4c. Thus, among the 
known PLC p isozymes, these results identify PLC P3 and/or PLC P4c as 
possible targets of Gao. I therefore cotransfected PLC p3 and overexpressed 
PLC P4c in C0S7 cells together with a l  adrenergic receptor. As shown in 
Fig.7, in cells expressing PLC p3 and PLC P4c, cotransfection of Gao-Q205L 
had no effect on a l  adrenergic receptor-mediated increase of inositol 
phosphate production. These results exclude PLC p3 and PLC p4c as direct 
targets o f ao.
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Fig. 8. Expression of PLC p i, PLC p2, PLC p3, and PLC P4 mRNA in 
Ltk and COS7 cells.
The upper diagram shows the generic structure of PLC p and the fragments 
predicted to be amplified by the specific PLC P-subtype couples of 
oligonucleotides. RNA fi*om the different samples was reverse transcribed 
using oligo(dT). PCR reactions were done with the selected primers as 
described in MATERIALS AND METHODS. PCR products were 
electrophoresed on a 1% agarose gel and stained with ethidium bromide. 
Panel A: RT-PCR for PLC p i. Panel B: RT-PCR for PLC P2. Panel C: RT- 
PCR for PLC p3. Panel D: RT-PCR for PLC p4. In all the samples RT-PCR 
was performed with (RT +) or without (RT -) Reverse-Transcriptase. All the 
reactions performed without RNA did not amplify any fragments (data not 
shown). Relative sizes of DNA markers (fXl 74, Biolabs) are shown on the 
left of each panel. Data are representative of two independent experiments for 
each panel.
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IDENTIFICATION OF A NEW VARIANT OF PLC P4
Diagnostic digestion of PLC P4 RT-PCR fragments
The experiments using RT-PCR carried out with primers amplifying a 
fragment of the C-terminal region of PLC p4a shown in Fig.8 , detected in the 
rat brain the expected fragment of 477 bp as well as an additional product of 
approximately 500 bp. In mouse Ltk" and C0S7 fibroblasts, the same reaction 
detected only the 500 bp band. The identity of the latter band was 
investigated by a diagnostic digestion with Bgl I-endonuclease which, as 
shown in Fig.9, gave a fragment of 282 bp common to the 477 bp and the 500 
bp bands and other two fragments which differed of about 50 bp. These 
results are consistent with the hypothesis that the two amplified products 
corresponded to two variants of PLC p4. This result was confirmed by 
diagnostic digestions with other restriction enzymes (data not shown).
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Fig. 9. Diagnostic digestion of PLC p4 RT-PCR fragments.
The amplification fragments from RT-PCR for PLC p4a were subjected to 
Bgll digestion. Sizes of DNA marker {pC174, Biolabs) are shown on the left. 
The top band corresponds to residual undigested product. Arrowhead 
indicates the 282bp fragment. Data are representative of two identical
experiments.
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Identification of PLC p4c sequence
Further analysis of the rat brain and Ltk" cells PCR products of approximately
500 bp revealed a sequence, termed PLC p4c, identical to PLC p4a with the
exception of an insertion of 37bp at 22 residues from the C-terminus. As a
result, the novel PLC P4 variant exhibits a completely different 41 residue C-
terminal tail (Fig. 10). PLC p4 homologues from rat, bovine and human have
been isolated with several exon variations (Alvarez et al. 1995; Ferreira et al.,
1993). Only the two characterized rat isoforms, PLC p4a and PLC P4b, differ
at their carboxyl termini (Kim et al., 1998). PLC P4a has an extensive
carboxyl terminal tail, is membrane-associated and activated by Gaq (Alvarez
et al., 1995). PLC p4c is also likely to be a membrane-associated protein and
activated by Gaq, since it contains the membrane association and Gaq
activation domains of PLC p4a. It is possible that the carboxyl terminal tails
of one PLC p isoform functions to localize this enzyme into a membrane-
associated signaling complex similar to that of NORPA. Such signal
transduction complexes may exist in neurons involved in visual processing.
Thus I screened a rat brain cDNA library to obtain clone(s) sufficiently long
to allow confirmation of the identity of the novel PLC p4 form. A 3.4Kb
clone of approximately ISOObp corresponding to the coding region and
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containing the extra sequence was then isolated. The N-terminal fragment of 
1700bp was amplified by RT-PCR, sequenced and ligated together with the 
C-terminal clone; the reconstructed full-length sequence of PLC p4c was 
finally subcloned into the expression vector pc-DNA I.
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Fig. 10. Identification of Pic |34c sequence.
Analysis of the PCR products of approximately 500 bp obtained with PLC (34 
primers from rat brain and Ltk' cells was performed as described in 
MATERIALS AND METHODS. It revealed a sequence, termed PLC P4c, 
identical to PLC p4a with the exception of an insertion of 37bp. Due to the 
frameshift caused by this insertion, in the deduced protein sequence o f PLC 
p4c, the C-terminal 22 residues of PLC p4a are replaced by 41 distinct amino 
acids. The results obtained with RT-PCR studies were confirmed by the 
isolation of seven independent PLC P4 clones from a rat brain cDNA library 
containing the 37 bp insertion. The longest clone 81A was used to reconstruct 
the full-length cDNA as described in MATERIALS AND METHODS.
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Identification of a protein corresponding to PLC p4c
To identify a protein product corresponding to the novel cDNA, I used a 
synthetic peptide (CGSRDGPQTSNSSMKL) to obtain a rabbit polyclonal 
antibody directed against the unique C-terminal sequence of PLC p4c. 
Application o f affinity purified preparations of this antibody in Western Blot 
analysis recognized a protein migrating at a rate corresponding to the 
expected size of 130 kDa in both rat brain and COST cells (Fig. 11). 
Expression of the 130 kDa protein was markedly increased after transfection 
of C0S7 cells with a full-length PLC p4c cDNA. The very high level of 
exogenous protein is likely secondary to high-level replication of the 
expression vector DNA (pcDNAJ) after transfection of C0S7 cells, that are 
immortalized with an origin-defective mutant of SV40.
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Fig. 11. Identification of a protein corresponding to PLC p4c.
A synthetic peptide represented in the upper diagram was used to obtain a 
rabbit polyclonal antibody directed against the C-terminal tail of PLC p4c. 
200 pg of membrane fractions from brain, C0S7 and transfected C0S7 cells 
were subjected to 7% SDS-polyacrylamide gel electrophoresis and 
immunoblotted with affinity purified preparations of the specific antibody as 
described in MATERIALS AND METHODS. Data are representative of 
three-five similar experiments.
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Screening for the expression of PLC p4b and PLC p4c
I next tested the pattern of expression of the different C-terminal variants of 
PLC P4. As mentioned in the Introduction, in addition to PLC P4a, a 
cytosolic variant has been described (PLC p4b) (Kim et al., 1998). As the 
cytosolic variant is mainly expressed in the cerebellum, this organ and the 
brain were studied by RT-PCR (Fig. 12), using two oligonucleotides that 
were discriminative for the deletion: the upstream primer (PB4Co) mapped at 
35bp from the deletion, the downstream primer (PB4RES) primed at 271 bp 
from the deletion in the 37bp extrasequence (see Fig. 10). The expected 
amplified fragments would have been 482bp for PLC p4c and 306bp for PLC 
p4b. By this approach, however, only the band corresponding to PLC pc was 
detected. Other several tissues, C0S7 cells and other cell lines gave similar 
results (data not shown). Moreover, RT-PCR reaction was performed with 
other couple of oligos, but the results were consistent with the former. These 
findings indicate two main possibilities: the first is that the cytosolic variant 
does not exist and the clone isolated and characterized by Kim et al. (1998) is 
a simple artefact. The second possibility is that the PLC pc cDNA has a 
secondary structure which does not allow the annealing of the oligos used for 
the reactions. This last hypothesis remains unlikely, as no trace of the 
fragment was amplified even at low stringency conditions of amplification.
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Fig. 12. Screening for the expression of PLC |34b and PLC (34c.
RT-PCR analysis of rat cerebellum and brain mRNA was performed using 
primers PB4Co and PB4RES amplifying a predicted 482 bp product for PLC 
(34c and a 306 bp product for PLC p4b. The reaction performed without RNA 
or Reverse-Transcriptase did not amplified any fragments (data not shown). 
The 482 bp product is indicated by an arrow. Sizes of DNA markers are 
shown on the left. Data are representative of two independent experiments.
108
Expression of PLC p4a and PLC p4c by RT-PCR analysis
The patterns of expression of PLC P4a and PLC p4c were compared. As 
shown in Fig. 13A, RT-PCR screening with primers amplifying the C- 
terminal region of PLC p4 (see Fig.8 ) showed expression of PLC P4a only in 
brain. In contrast, the PCR product corresponding to PLC p4c was identified 
in brain, C0S7 and Ltk- fibroblasts and was clearly detectable also in 
pituitary gland, lung, kidney, spleen, thyroid FRTL5 cells, pituitary GH4 C 1 
cells and chromaffin PC 12 cells. The identity of the PCR fragment obtained 
in the various samples was confirmed by hybridization with a probe 
corresponding to the 37bp extrasequence (Fig. 13B). It is important to note 
that no PLC p4c was detected in liver and very little in spleen or COS7 cells, 
analogous to the expression pattern of G Œo (Price et al., 1989; Strathmann et 
al., 1990). This correlation of the expression patterns of PLC p4c and G Œq 
could reflect the existence of a pathway in which both the proteins are 
involved.
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Fig. 13. Expression of PLC p4a and PLC p4c by RT-PCR analysis.
Total RNA was extracted from Sprague Dawley rat tissues and indicated cell 
lines and reverse-transcribed as described in MATERIALS AND 
METHODS. PCR (A) was performed as described in the legend to FIG 8 . 
The data are representative of two independent experiments. The identity of 
the PCR fragment obtained in the various systems was confirmed by 
hybridization with a specific probe (B) as described in MATERIALS AND 
METHODS.
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Western Blot analysis of the expression of PLC p4c
I tested the same samples used for RT-PCR screening and some other tissues 
by immunoblot analysis with PLC p4c-specific antibody (Fig. 14), as RT- 
PCR tecnique detects mRNA presence, but not for the effective expression of 
the protein. In spite of the positivity of the RT-PCR results, a clear signal in 
Western Blot was detectable in brain, cerebellum, lung, and all the cell lines, 
but not, as expected, in liver and hippocampus. A detectable signal 
corresponding to the protein was also absent in pituitary gland, kidney and 
spleen which were positive in RT-PCR screening. This was probably due to 
the low affinity of the specific antibody for the protein or to a lower level of 
expression or to an higher rate of degradation of the protein or to a 
combination of the above. Additional bands (immediately above and/or 
below the expected one) could suggest the existence of additional 
uncharacterized splicing variants of PLC (34c, even if  they were not detected 
by the antibody when affinity purified (see C0S7 cells lane in Fig. 11).
In summary, these results suggest that, in contrast to PLC (34a which seems 
mainly localized in brain, PLC (34c is more widely expressed even if in 
several tissues the mRNA is present but does not correspond to a comparative 
expression of the protein.
I l l
Tissues and RT-PCR Western Blot
cell lines PLC P4a PLC p4c PLC P4a PLC p4c
brain + + + + + +
cerebellum ++ +++ +++ +++
hippocampus not tested not tested - -
pituitary - + + - -
liver - - - -
lung - ++ - +++
kidney - ++ - -
spleen - + - -
heart not tested not tested - +
Ltk" - + - ++
C0S7 - + - +
GH4C1 - + - +
PC12 - ++ - +
FRTL5 - +++ - ++
Table 3
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Fig. 14. Western Blot analysis of the expression of PLC P4c.
200 pg of the particulate fractions of indicated samples were immunoblotted 
as described in the legend to Fig. 12 and probed with anti-PLC P4c antibody 
affinity purified on sepharose-protein G columns (see MATERIALS AND 
METHODS). The bands above and below the 130 kDa band could 
correspond to a specific products recognized by the anti-PLC p4c antibody 
affinity purified on sepharose-protein G columns, as they were not detected 
by the same antibody purified by peptide-affinity (see Fig. 12). The relative 
molecular mass marker is shown to the left. Data are representative of two 
independent experiments.
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Analysis of subcellular distribution of PLC p4a and PLC p4c
The C-terminal region of PLC p is known to be involved in membrane 
attachment of the enzyme (Kim et ah, 1996). To assess possible functional 
differences between PLC p4a and PLC p4c, I therefore compared the 
subcellular distribution of the two enzymes. Separate analysis of soluble and 
particulate fractions revealed that, in agreement with previous findings, most 
of the PLC P4a was bound to membranes in both rat brain and transiently 
transfected C0S7 cells (Fig. 15). PLC P4c displayed the same pattern of 
localization.
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Fig. 15. Analysis of subcellular distribution of PLC p4a and PLC p4c.
C0S7 cells were transfected with 10 pg PLC p4a or PLC p4c as described in 
MATERIALS AND METHODS. Rat brain and transfected COS7 cells were 
fractionated as described under MATERIALS AND METHODS. 200 jug of 
soluble (S) or particulate (P) fractions were subjected to 7% SDS- 
polyacrylamide gel electrophoresis and electroblotted. The blots were 
incubated with anti-PLC P4a or anti-PLC p4c antibodies as described in the 
legend to Fig. 12. Data are representative of two independent experiments. 
The relative molecular mass marker is shown to the left.
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PLC P4c is activated by G protein an and not by py subunits
To assess functional properties of the PLC P4a and PLC P4c variants, I
investigated their pattern of regulation by Gaq and Gpy subunits. Expression
vectors carrying the full-length cDNAs corresponding to phospholipase C
p4a and p4c were cotransfected into C0S7 cells together the a  subunit of Gq.
As shown in Fig. 16A, transfection with vector, PLC P4a or PLC p4c leads to
a low level of inositol phosphate accumulation. When Gaq was transfected, in
agreement with previous observations (Jiang et ah, 1994; Kim et ah, 1998),
there was an approximately 18% increase in total inositol phosphate
formation compared with vector alone. When the cells were cotransfected
with Gaq and increasing concentrations of PLC P4a or PLC p4c, inositol
phosphate formation progressively increased, with both the variants o f PLC
p4 equally responsive to the a  subunit. To exclude the possibility that these
results could be due to a differential expression of PLC (34 or Gaq in
transfected cells, we performed an immunoblot analysis using specific
antibodies. These experiments confirmed that the amounts of PLC (34a and
PLC (34c correlated with the increasing concentrations of transfected vectors
and that the expression levels of both PLC (34 and Gaq were not affected by
cotransfection. To test whether the two variants differ in their sensitivity to
Gaq, COS7 cells were cotransfected with the maximal concentration o f PLC
p4a or PLC P4c and increasing concentrations of Gaq. As shown in
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Fig.l6/B, the two curves of response to Gaq were super-imposable for the 
two enzymes. These results show that the two alternative C-terminus of the 
two variants have no effect on interaction with Gaq, consistently with the 
identification of the region deputated to this function just upstream of the C- 
terminus of PLC p4 protein (Wu et ah, 1993). Finally, I tested the activation 
of PLC P4a or PLC p4c by GP1Y2 and GP2Y2 subunits. These combinations 
have been shown to be the most effective in PLC activation (Hawes et ah, 
1995). As shown in Fig.l6C, GP1Y2 and GP2Y2 induced per se an 
approximately 100% and 40% increase of IP production, respectively, which 
is the effect o f endogenous PLC stimulation by the excess of free 
Py complexes. In agreement with previous findings (Jiang et ah, 1994), 
expression of these subunits did not induce a significant stimulation of PLC 
P4a. Experiments with PLC p4c revealed that also this variant was
of
GP1Y2 and GP2Y2 with PLC p4 seems to diminish the effect of Py. This effect 
could be due to a sort of desensitization of endogenous PLC activity by the 
overexpressed PLC p4 variants, which could create a loop of negative 
feedback on the basal PLC enzymes. Taken all together, these results suggest 
that both PLC p4a and PLC P4c participate in phosphoinositide hydrolysis 
by G protein-coupled receptors via Gaq and not via GPy subunits.
unresponsive to GP1Y2 and GP2Y2. On the contrary, co-transfection
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Fig. 16. PLC p4c is activated by G protein aq and not by Py subunits.
A: activation of PLC p4a and PLC p4c by Gaq. Cells were transfected with 5 
\ig of Gaq vector and the indicated doses of PLC P4a and PLC P4c cDNA as 
described under MATERIALS AND METHODS. The level of total inositol 
phosphates was determined 48 hrs after transfection (see MATERIALS AND 
METHODS). Data are presented as percentage of IP accumulation in cells 
transfected with pcDNAI alone. The data shown are the means ± S.E. of three 
independent experiments performed in triplicate. The blots show expression of 
Gaq and the two forms of PLC p4 in C0S7 cells transfected with the indicated 
cDNAs. The relative molecular mass markers (in kDa) are shown to the left. B: 
dose-dependence of the activation of PLC p4a and PLC p4c by Gaq. Cells 
were transfected with 5 pg of PLC p4a or PLC p4c and increasing doses of 
Gaq vector. The experiments were performed as described for Panel A. Data 
shown are means ± S.E. of two-three independent experiments in triplicate 
determinations. C: effect of G-protein Piy2 and ^272 complexes on PLC P4a 
and PLC p4c. C0S7 cells were transfected with 5 pg of Pi, p2, Ji, PLC P4a 
and PLC p4c. The experiments were performed as described for Panel A. 
Given values are means ± S.E. of two experiments in triplicate determinations 
(n=9; p<0.05 T-test).
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Effect of G tto on polyphosphoinositide hydrolysis
Several studies have shown that various receptors coupled to PTX-sensitive 
G proteins inhibit polyphosphoinositide hydrolysis. However, the evidence 
concerning the specific G protein subunit(s) involved in these responses is 
still incomplete.
The experiments presented here demonstrate that the constitutively active 
form of Gao, when stably expressed in Ltk" cells, inhibits agonist-induced 
stimulation of inositol phosphate production. Since a similar effect was not 
observed in transient transfection experiments carried out with C0S7 cells, 
one cannot exclude the possibility that the results obtained in Ltk" clones be 
due to compensatory mechanisms or irrelevant effects resulting from the 
prolonged expression of the mutant protein. However, the fact that a 
relatively short treatment of Ltk" cells with Na-butyrate, which increases the 
levels o f expression of the transfected protein, markedly enhanced inhibition 
of inositol phosphate production by G a^  certainly supports the idea of an 
inhibitory influence of ao-
The effect of Gao on inositol phosphate production can be accounted for by 
the regulation at the level of all components involved in this response: these 
include the stimulatory receptors, the stimulatory G protein subunits and the
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PLC P enzymes. In addition, there is the possibility that Gao might inhibit 
stimulation of inositol phosphate production by affecting the synthesis or 
metabolism of membrane phospholipids. To investigate the target of Gao, I 
identified by RT-PCR analysis the PLC P subtypes present in Ltk" cells. 
These studies revealed the expression of both PLC p3 and PLC p4c. 
However, in C0S7 cells transfected with these enzymes, upon stimulation of 
the a  1-adrenergic receptor, which can couple to all the a  subunits of the Gq 
family (Wu et al., 1992), Gao failed to inhibit IP production. Possible 
explanations of these negative results include the fact that Gao acts on an 
unknown PLC P, present in Ltk" but not in C0S7 cells, or inhibits PLC P3 
and/or PLC p4c through additional component(s) which are not available in 
the C0S7 line. Thus, among the PLC p enzymes, PLC p3, PLC p4 or another 
unknown PLC p subtype remain the possible targets of Gao in the Ltk" cell 
model.
The component of the phosphoinositide hydrolysis signalling system 
sensitive to Gao could be regulated by this subunit either directly or via other 
effector(s) and intracellular pathway(s). The results obtained in Ltk" cells 
seem to exclude both the inhibition of adenylate cyclase and suppression of 
Ca^ "^  influx, as mediators of the effect o f Gao in Ltk" cells. However, many 
other signals involving PKC, PI3K, Src kinases and MAPK, all o f which 
have been recently shown to be activated by Gao (Kroll et al., 1991; van
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Biesen et al., 1996; Ram et al., 1999), could possibly affect the PLC 
signalling system. Further experiments are clearly needed to elucidate the 
target(s) and the mechanism(s) of action involved in Gao regulation of 
phosphoinositide hydrolysis.
In conclusion, my findings indicate that expression of constitutively active 
Gao can inhibit the cellular response to receptors stimulating 
phosphoinositide hydrolysis. The results obtained in COST cells suggest that 
this effect o f Gao occurs only in specific cell types. Interestingly, a genetic 
study in the nervous system of C. elegans has shown that the Gao 
homologue, GOA-1, negatively regulates the Gaq homologue, EGL30, 
pathway, which activates the PLC p4 homologue, EGL8 (Miller et al., 
1999). It seems therefore quite possible that a Gao-mediated signal represents 
at least one of the events responsible for the ability o f Gi/o-coupled receptors 
to inhibit phosphoinositide hydrolysis in certain cellular systems.
In the last two years, several studies have characterized different signalling 
pathways in which Gao is involved, but not concerning PLC activity. In 
particular. Ram et al. (2000) have shown that the expression of mutant Gao 
Q205L in NIH-3T3 cells results in transformation through the activation of 
the Stat3 signaling pathway. A different study by Dhingra et al. (2000, 2002) 
has revealed that Gao 1 variant is required by retinal ON bipolar cells for the 
response to rod and cone input: glutamate released into retinal ON bipolar
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neurons binds to a metabotropic receptor to activate Gao that ultimately 
closes a nonspecific cation channel. Signaling requires the Gao, but its 
effector is unknown.
In rat hippocampal synapses, Gao seems to be involved together with other 
PTX-sensitive G a subunits in presynaptic inhibition triggered through the 
interaction with specific GPCRs (Straiker et al., 2002). To date, there is no 
evidence in the literature on the a regulation of the PLC signaling pathway by 
Gao. Thus, the results contained in this thesis remain to be clarified.
The PLC p4c enzyme 
The PLC p family of enzymes is involved in G protein-dependent signalling 
pathways. PLC p subtypes varying in both the N-terminal and in the C- 
terminal regions have been characterized. The results of PCR amplification 
and rat brain cDNA library screening reported here indicate the existence of a 
novel C-terminal variant of PLC P4, named PLC P4c. The same sequence has 
been recently described by Adamski et al. (1999). However, no 
characterization of the distribution and functional properties of PLC p4c was 
performed in the latter study. The 1880 bp-long clone encoding PLC P4c that 
we have analyzed shares its sequence with the previously identified PLC p4a 
enzyme, with the insertion of an additional 37 bp of C-terminal sequence. 
Although it cannot be ruled out that PLC p4a and PLC p4c are the product o f 
different genes, it appears quite likely that the two mRNAs are generated by
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alternative mRNA processing. This possibility is supported by the previous 
identification of splicing variants o f several PLCP enzymes including rat 
PLC-pl (Bahk et al., 1994), bovine PLC-p4 (Ferreira et 
al., 1993), Drosophila PLC-p21 (Shortridge et al., 1991), and Drosophila 
norpA PLC (Kim S. et al., 1995). The splicing in all of these PLC isozymes 
occurs outside the X and Y catalytic domains. Importantly, alternative 
splicing in the C-terminal regions of the rat PLC p i and the Drosophila PLC- 
p21 has been reported (Bahk et al., 1994; Shortridge et al., 1991). 
Characterization of the expression patterns of PLC P4 has only been reported 
for the rat brain. Results obtained by RNA hybridization of tissue sections 
and immunodetection by using an antibody raised against the N-terminal 
region of PLC P4 (common to PLC p4a, -b and -c) indicate that its 
expression is highest in the cerebellum and almost negligible in the cerebral 
cortex and hippocampus (Tanaka et al., 1994; Adamski et al., 1999). My RT- 
PCR experiments detected PLC p4a in the brain, in agreement with previous 
findings, but not in other organs. In contrast, PLC p4c mRNA is present in all 
tested tissues, except the liver, and cell lines. Immunoblot analysis detected a 
significant signal for PLC p4c only in brain, cerebellum, lung, heart, C0S7, 
GH4, FRTL5, Ltk' and PC 12 cells with the highest levels in the cerebellum. 
The absence of a band corresponding to PLC p4c in several of the tissues 
examined by Western Blotting could be explained by very low levels of
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enzyme expression that are below the threshold of detection by our antibody, 
or to a major rate of degradation of the enzyme. Despite this limitation, the 
data indicate that PLC p4a is mainly, if  not exclusively, present in the brain, 
whereas PLC P4c has a more widespread distribution.
The different patterns of expression suggest that the two variants could have 
different functions. The novel cDNA for PLC P4c has an insertion of 37bp 
that results in the replacement of the 22 C-terminal amino acids of PLC p4a 
with 41 different amino acids. Previous studies have identified the C-terminal 
region of PLC p enzymes as responsible for association to the particulate 
fraction (Kim et al., 1996) and activation by Gaq (Wu et al., 1993). By 
creating a series of deletion mutants, Wu et al. (1993) found that the region 
between residues Thr-903 and Gin-1030 (P-Box) is necessary both for 
association of PLC p i with the particulate fraction and its activation by Gaq. 
This report also showed that the region between residues Lys-1031 and Leu- 
1142 (G-box) is required for interaction with the G protein Œq subunit but is 
not necessary for association o f PLC p i with the particulate fraction. The P- 
box in PLC pi is the most lysine-rich region in the entire molecule. It was 
therefore suggested that association with the particulate fraction might occur 
through phospholipid or some intermediate negatively charged membrane- 
bound proteins. Other studies have demonstrated the importance of the C- 
terminal basic residues of PLC p i as well as PLC p2 for membrane
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association (Park et al., 1993; Lee et al., 1993; Kim et al., 1996). I found that 
both variants of PLC p4 are mainly localized in membranes and are sensitive 
to GoCq. These results are consistent with the above discussed studies 
identifying the region required for membrane association and interaction with 
Gaq upstream to the C-terminal end of the protein (Wu et al., 1993).
Kuang et al. (1996) proposed that the Glu-435 to Val-641 region o f the PLC 
p2 molecule is involved in the interaction with the G protein py subunits. 
Binding assays using glutathione S-transferase-fused PLC p2 and pure G 
protein py subunits further narrowed the region down to 62 amino acids 
(residues Leu-580 to Val-641). These residues of PLC p2 are located inside 
the catalytic Y-domain, highly conserved among PLC isozymes. Although it 
has been previously shown that PLC p4a cannot be activated by G protein 
py subunits (neither in vitro nor in vivo), and the analysis o f the two variant 
sequences tended to exclude a different regulation of PLC p4c, I checked this 
possibility in transfected COS7 cells. As expected, in my experimental 
system, PLC p4c proved to be unresponsive to two different combinations of 
(iPy.
It should be mentioned that Kim et al. (1998) identified a variant o f PLC P4, 
PLC p4b, which appears to be localized in the cytosolic fraction and to be 
insensitive to Gaq. These authors isolated two PLC p4b clones but selected 
for further analysis only the one containing the longer cDNA insert. The
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overall cDNA structure o f this clone was almost identical to the PLC p4a 
mRNA except for a 176 bp deletion in the C-terminal region of the protein. 
As a result, the C-terminal 162 amino acids of PLC p4a are replaced by 10 
distinct amino acids in PLC p4b. Western Blot analysis with an antibody 
directed against the N-terminal portion of PLC p4 and an anti-PLC p4b 
specific antibody, identified the truncated variant in the brain cytosol. Further 
immunocytochemistry studies, not shown in the report, apparently revealed 
high levels of PLC P4b in the cytoplasm of Purkinje cells of rat cerebellum. 
Using diagnostic RT-PCR, I tested brain, cerebellum and various tissues and 
cell lines for the presence of PLC p4b, with negative results. Clearly, further 
studies will be necessary to clarify this issue.
Although my experiments did not reveal any functional differences between 
PLC p4a and PLC p4c, there is an interesting feature that distinguishes the 
cDNA sequences of the two variants. Only PLC-p4a contains a C-terminal 
consensus sequence (Thr-Val-Val-COO-) for the PDZ domain-binding site 
(see Fig. 10). PDZ domains are multifiinctional protein interaction motifs 
which provide a fi'amework for the recruitment of target molecules into 
membrane-bound macromolecular complexes. These domains bind to 
specific sequences at the C-terminus of the interacting proteins. Most 
interestingly, the Drosophila PLC, norpA, is an integral part o f a signal 
transduction complex organized by a PDZ protein, INAD, which binds and
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clusters protein kinase C, the TRP calcium channel, and norpA in a complex 
associated with the rhabdomere membrane. Recent results (van Huizen et al., 
1998) have shown that Drosophila INAD, which contains five tandem PDZ 
domains, directly binds norpA via two terminally positioned PDZl and PDZ5 
domains. PDZl binds to the C-terminus of norpA, while PDZ5 binds to an 
internal region overlapping with the G box-homology region. The norpA 
proteins lacking binding sites, which display normal basal PLC activity, can 
no longer associate with INAD in vivo. These truncations cause significant 
reduction of norpA protein expression in rhabdomeres and severe defects in 
phototransduction. The vertebrate PLC P4a shares greater similarity with 
norpA than with other PLC P isotypes (Kim et al., 1993; Lee et al., 1993). 
This suggests that regulation of PLC P4a-mediated signal transduction may 
be similar to the norpA-mediated mechanism involved in visual transduction 
in Drosophila. It is therefore possible that the presence of a putative PDZ- 
binding region in PLC P4a, which is expressed in the brain, and not in the 
more ubiquitous PLC p4c, determines the selective involvement of PLC P4a 
in specific signal transduction pathways operating in neurons (Jang et al., 
1996; Kim et al., 1997). Besides, potential phosphorylation sites can be 
identified in PLCP4c C-terminal tail (serine residues) which could be 
involved in specific pathways of regulation of PLC; indeed the PKC- 
dependent phosphorylation of PLC P3 isozyme was shown to be involved in
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desensitization of PAF- (Ali H. et al., 1997) and opioid receptor-mediated 
(Strassheim et al., 1998) phosphoinositide hydrolysis and Ca^ *^  mobilization. 
In conclusion, this thesis has shown the existence of:
-a novel mechanism of inhibitory regulation of G protein-coupled receptor- 
mediated activation of PLC is triggered by activated Gtto subunit in a specific 
cell type, Ltk" cells. The pathway and the proteins involved remain to be 
characterized. To this aim:
-the possible involvement of intermediate messengers as src-like kinases, 
PKC, Rapl, P14K, MAPK should be tested by using specific inhibitors or 
activators.
-transient transfection experiments should be performed in another mouse 
cell line than C0S7 cells, which is not transformed by SV40 and expressing 
endogenous Gao subunit.
-a novel C-terminal variant of PLC P4, PLC P4c. This enzyme is widely 
distributed, in contrast to the known variant PLC P4a, which is expressed 
only in brain and contains a putative PDZ domain-binding sequence, 
probably involved in the formation of neuronal specific multiprotein 
complexes. On the contrary, PLCP4c does contain three putative 
phosphorylation sites in its specific C-teminal sequence which are absent in 
PLC P4a: Thr^^^  ^ and Ser^ "^^ .^ These sites could represent targets for
regulation by Ser/Thr kinases, analogously to PLCPS (Xia et al., 2001); in
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particular, Ser^ "^^  ^ is a putative phopshorylation site for PKC. Both the 
variants are equally responsive to G protein subunits; functional differences 
between the two isoenzymes have to be investigated. To this aim, several 
issues could be analyzed:
-characterization of both the variants expression at different stages of 
embryonic development and in adult tissues by in situ hybridization and 
immunocytochemistry (technical problems due to the low affinity of PLC P4c 
antibody could be bypassed by tag-labeling).
-identification of PDZ domain containing proteins binding to PLC P4a in 
retina (like INAD for NORPA) or cerebellum (like Homer which couples to 
mGluR) by two-yeast-hybrid system or immunoprécipitation assays 
-characterization the function of the two variants C-terminal tails by site- 
directed mutagenesis experiments and by phosphorylation assays.
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MATERIALS AND METHODS
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PLASMID DNAs
The expression vectors used for stable transfection of Ltk' cells were pMV7, 
pMV7- ŒoWt, pMV7- ttoQL, pMV7- a^wt, pMV7- a^QL, kindly provided by 
Dr. Y. Wong. Transient transfections were performed with the following 
vectors: pcDNAI (Invitrogen); pREP8 andpl63REH-PLCp3 kindly provided 
by Dr Weber Gunther (Dept, of Molecular Medicine, Karolinska Institutet, 
Sweden), pcDNAI-Gaq, pcDNAI-a^wt, pcDNAI-a^QL, pcDNAI-pl,
pcDNAI-P2 and pcDNAI-y2 gently provided by B. Yung (The Hong Kong 
University of Science and Technology, HKUST); prk5 and prk5-alA R 
gently provided by Dr. Susanna Cotecchia (Institut de Pharmacologie et de 
Toxicologie de Lausanne, Switzerland) and pcDNAI-PLC P4a, pcDNAI-PLC 
P4c which were reconstructed in our laboratory as described below.
These plasmid DNAs were all amplified by M C I061 strain oîE.coli.
STABLE TRANSFECTION OF Ltk' CELLS
Ltk' cells (mouse fibroblasts) were transfected with pMV7, pMV7-ao WT,
pMV7-ao QL, and pMV7-aü WT by the CaPO^ method (Graham and van
der Eb, 1973) and were selected by growth in the presence of 400 |Lig ml'^ 
G418. Individual clones were generated from the infected G418-resistant
pools by limiting dilution. Uninfected cells, G418-selected pools and clonal
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lines were mantained in colture in Dulbecco’s modified medium 
supplemented with 10% fetal calf serum in 5% CO2.
PLASMID DNA PREPARATION
A single colony of the bacterial strain carrying the plasniid was picked up 
from a freshly streaked plate containing 40 mg/ml ampicillin and inoculated 
in 5 ml Luria Broth (LB) containing 40 mg/ml ampicillin. The starter culture 
was incubated for 6h at 37 with vigorous shaking (300 rpm) and then 
diluted 1 : 500 into selective LB medium (500 ml). The culture was grown at 
37 °C for 16 h with vigorous shaking till reaching an O.D. (600 nm = 2)
corresponding to a cell density of 2 x 10^ cells/ml.
Bacterial cells were harvested by centrifugation at 6000 x g for 15’ at 4 °C. 
The pellet was resuspended in 38 ml resuspension buffer (50 mM glucose, 25 
mM Tris-HCl pH 8, 10 mM EDTA) containing 100 |ig/ml RNAse. Then 40 
ml of lysis buffer (0.2M NaOH, 1% SDS) were added; the suspension was 
gently mixed and incubated for 10’ at room temperature. Finally, 20 ml of 
chilled neutralization buffer (3 M K-acetate, 11.4% acetic acid) were added, 
mixed and incubated for 15’ at 4 °C. The suspension was then centrifuged at 
11500 X  g for 30’ at 4° and the supernatant was centrifuged again for 15’ and 
filtered in another tube. To precipitate DNA and partially solubilize RNA 
60ml of isopropanol were added and incubated for 15’ at room temperature. 
The solution was centrifuged at 11500 x g at 4° for 15’. The supernatant was
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decanted and the pellet resuspended in TE (10 mM Tris pH8, 1 mM EDTA) ; 
740 p-g/ml of ethidium bromide and Ig/ml CsCl were added. The suspension 
was centrifuged at 2500 x g for 15’ at 4 °C to precipitate RNA and protein 
residues. The supernatant was filtered in Beckman Quick-Seal tubes 
(362181) and centrifuged in Beckman ultracentrifuge (TiV65 rotor) at 
275000 Xg for 16 h a t 20 °C.
Two bands of DNA were visible in ordinary light (nicked circular plasmid 
DNA and closed circular plasmid DNA) and were collected into a 10ml 
siringe. Ethidium bromide was removed by adding 1 volume of isobutanol 
saturated with water, mixing and removing the upper organic phase. The 
extraction was repeated six to eight times until the pink color disappeared 
from both the phases. The aqueous phase was transferred into a Corex tube, 
diluted with 3 volumes of water (to remove CsCl) and 0.1 volume of Na- 
Acetate 3M pH5 and 2 volumes of ethanol 98% were added to precipitate 
DNA. The solution was incubated for 15’ at 4° and then centrifuged at 
16000xg for 10’ at 4 °C. The supernatant was discarded and the pellet was 
resuspended in 400 ml TE and stored at -20°.
TRANSIENT TRANSFECTION OF C0S7 CELLS
C0S7 cells were mantained in Dulbecco’s modified medium supplemented 
with 10% fetal calf serum in 5% CO2 and were transfected by the DEAE-
dextran method (Cullen B.R., 1987). Cells were seeded.at 2x10^ cells/60 mm
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dish and transfected 24 h later by incubation with 4ml of transfection mixture 
(15pg of plasmid DNA in DMEM/10% FCS containing 0.1 mM cloroquine 
and 0.4 mg/ml DEAE-dextran) for 4 hr. Cells were shocked with phosphate- 
buffer saline (0.13 M NaCl, 2.7 mM KCl, 8.1 mM Na2HP0 4 , 1.47 mM 
KH2PO4) containing 10  % dimethyl sulfoxide for 2  min, then washed once 
with phosphate-buffer saline and mantained in growth media for 24 h.
MEASUREMENT OF INOSITOL PHOSPHATE (IP) 
ACCUMULATION
For experiments with Ltk" clones, cells were seeded at 2 x 10  ^ cells/well in 
12-well plates and 24 h later were incubated with myo [H inositol (4 
jiCi/ml) for 48 h. When requested, Na-butyrate was added to a final 
concentration of 10 mM for 36 h and pertussis toxin (PTX) was added to a 
final concentration of 0.1 |ig ml’  ^ for 16 h. The cells were washed with 2 
ml/well of assay medium (10 mM Hepes-buffered Dulbecco’s modified 
Eagle’s medium without serum and antibiotics) and incubated in the same 
medium at 37 °C for 1 h. Then cells were preincubated for 10 min at 37 °C 
with 1 ml o f assay medium containing 20 mM LiCl and stimulated or not for 
1 h at 37 °C with 100 |iM ATP or LPA. After incubation, the medium was 
aspirated and cells were lysed by addition of 0.75 ml of ice-cold 20 mM 
formic acid. After 30 min, plates were centrifuged at 1000 x g for 10 min at 4
°C and the supernatant fractions were loaded onto Dowex 1x8 columns,
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followed by immediate addition of 3 ml of 0.2% ammonium hydroxide 
([^H]inositol fraction). The columns were then washed with 10 ml of 40 mM 
ammonium formate/0.1 M formic acid followed by 4 ml of 2 M ammonium 
formate/ 0.1 M formic acid ([^H]IP fraction). Combined radioactivity in these 
two fractions correlated directly with the number of the cells in each well.
Accordingly, data are presented as the quotient of [^H]IP divided by [^H] 
inositol plus [^H] IP.
For experim ents w ith  COS7 cells, 24 h after transfection each 60-mm dish 
of cells was tiypsinized and resuspended in 8ml growth medium. This 
suspension was plated in 24-well plates (1 ml/well) and incubated with
myo[^H]inositol (5 pCi/ml). 24 h later the cells were washed twice with 2 ml 
of assay medium (10 mM Hepes-buffered Dulbecco’s modified Eagle’s 
medium without serum and antibiotics) and incubated at 37 °C for 15 min 
with 400 ml of assay medium containing 10 mM LiCl. After addition of 400 
ml of the same medium with or without 2  pM phenylephrine, cells were 
incubated for 30 min at 37°. The medium was then aspirated and cells were 
lysed by addition of 0.75 ml of ice-cold 20 mM formic acid. Inositol 
phosphate were separated as described above.
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MEASUREMENT OF cAMP
For these experiments, confluent cells in 24-well plates were washed twice 
with 1 ml of assay medium (lOmM Hepes-buffered Dulbecco’s modified 
Eagle’s medium without serum and antibiotics), and incubated in 500 pi o f 
the same medium containing 1 mM IBMX for 10 min at 37 °C in the absence 
or presence of 20 pM forskolin. Reactions were terminated by aspiration of 
the medium and addition of 500 pi boiling acetate buffer (0.5 mM sodium 
acetate pH 6.2). After 20 min, the plates were centrifuged at 1000 x g for 10 
min at 4 °C. cAMP was determined by radioimmunoassay using a 
commercial kit (Du Pont New England Nuclear). The DNA content of the 
wells was determined as described (Valente et al., 1983).
REVERSE TRANSCRIPTION-PCR ANALYSIS
To detect expression of the various PLC p isozymes, total RNA was
prepared fi*om Ltk' cells rat brain and HL60 cells using the guanidinium 
thiocyanate phenol-based single-step method (P.Chomczynski, N.Sacchi, 
1987). cDNA was synthesized by using the GeneAmp RNA PGR Kit (Perkin 
Elmer) according to the protocol suggested. For PLC p i, the reaction 
proceeded for 35 cycles of 94 °C for 1’, 60 °C for 45” , and 72 °C for 2’. The
two primers used were: PB IF (5’-GACTCATCCAACTACATGCC-3 ’) and
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PBIR (5’-GTCTGCGCCTCTACTTCTGT-3’). For PLC p2, the reaction 
proceeded for 35 cycles o f 94 °C for 1% 60 °C for 45” , and 72 °C for 2 ’. The 
two primers used were: P2/3F (5’-GACTCCTCCAACTACATGCC-3’) and 
PB2R (5’-CTGGACTCGCCAGTGGGAA-3’). For PLC P3, the reaction 
proceeded for 35 cycles o f 94 °C for 1’, 60 °C for 1’, and 72 °C for 2’. The 
two primers used were: PB2/3F (previously described) and PB3R (5’- 
AAGCTGGGTGTTTTCCTCCT-3 ’). For PLC p4, the reaction procedeed for 
35 cycles of 94 °C for 1 min, 60 °C for 1 min, and 72 °C for 1 min. The two 
primers used were: PB4F (5'-AGATTGTGGCGCAGCACACA-3’) and PB4R 
(3’-CTGTTGCTGGTCTGCGGTC-5').
To investigate the pattern of expression of PLC p4a and PLC P4c, total RNA 
was prepared from adult rat tissues as described above.
For detection of PLC P4a and PLC P4c, the reaction procedeed for 35 cycles 
of 94 °C for 1 min, 60 °C for 1 min, and 72 °C for 1 min. The two primers 
used were: PB4F and PB4R.
For detection of PLC P4b and PLC p4c, the reaction proceeded for 30 cycles 
of 94 °C for 1 min, 56 °C for 1 min, and 72 °C for 1 min. The two primers 
used were: PB4Co (5’-AGATTCAGACCCTGACATC-3’) and PB4RES (5’- 
CACTGCATGACAGGATTTCAA-3 ’). Oligonucleotides were synthesized 
by Primm (DiBit, Milano). All amplified products were analyzed in a 1% 
agarose gel stained with ethidium bromide. The DNA molecular weight 
marker used to discriminate the bands was fiCl 74, New England Biolabs cod. 
N. N3026S.
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cDNA sequencing
cDNAs amplified in RT-PCR were eluted from the agarose gel and 
sequenced by the Sequenase PCR Product Sequencing kit (US70170, 
Amersham), using primers PB4F and PB4R and PB4F2 (5’- 
AGAGACTGGCAATGAAGCA-3 ’).
Southern Blot
1 % agarose gels containing RT-PCR products were fixed for 20’ in NaOH 
0.4 N and blotted for capillarity in SSCI OX (1.5 M NaCl, 0.15 M Na-cytrate) 
overnight on a nylon membrane (Biodyne, B. PALL) . The membrane was 
washed in SSC2X, fixed for 2 h at 80 °C and prehybridized for 6  h at 50 °C 
with 25ml hybridization buffer (0.125M Na2HP0 4 , 8 % H3PO4, 1 mM EDTA 
pH 8 , 0.25M NaCl, 7% SDS, 10% PEG8000, 1% BSA) containing 0.2 mg/ml 
predenaturated salmon sperm. It was then hybridized for 16 h at 50 °C with 
15ml of the same hybridization buffer containing 0.4 mg/ml salmon sperm 
and 15 x 10  ^ cpm of [^^P]adCTP labelled probe 5’- 
CTTTTGAAATCCTGTCATGCAGTGTCCCAAACACAAG-3 ’. This probe 
was synthetized by Primm, labelled by Random Priming method according to
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the standard protocol o f DecaPrime II, Celbio Ambion and purified by G50 
columns, Pharmacia. The membrane was washed with SSC2X/0.1%SDS for 
30’ two times and exposed for 15’ at -80 °C to Kodak (X-OMAT AR) film.
CLONING OF PLC P4a AND PLC P4c
Isolation of cDNA
Two DNA probes were used to screen a rat brain XZapII cDNA library in 
order to identify clones containing sequences corresponding to PLCP4 a and 
PLCp4 c variants. Two clones were identified by PCR analysis on phages 
which corresponded to the two proteins. Both the clones contained the 3’ 
terminal of the sequence.
The two clones (11 A, 3,5Kb long, for PLC P4a and 81 A, 3,4Kb long, for 
PLC p4c) were plaque purified and subcloned into Bluescript vectors 
(respectively named 3’ SK p4a and 3’ SK p4c) by in vivo excision with 
ExAssist helper phage. To characterize the phagmides rescued, a restriction 
analysis and a sequence analysis were performed (radiolabeled reaction with 
Sequenase Kit Version 2 and sequence detection by vertical gel 
electrophoresis).
Isolation of full-length cDNA encoding PLC P4a and PLC P4c
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In order to obtain the 5’ sequence o f PLC P4 cDNA, total RNA was prepared 
from adult Sprague Dawley rat brain tissue using the guanidinium 
thiocyanate phenol based method (Chomczynski and Sacchi, 1987). RNA 
was reverse transcribed with a specific antisense primer (oligo B: 5’- 
CGGCTCATTTGTCGCTTATTG-3’) encompassing the 5’ terminal o f both 
the clones l lA  and 81 A. The reaction was performed in a 20 \il mixture 
containing 50 mM Tris-HCl pH 8.3, 3 mM MgCl2, 75 mM KCl, 0.5 mM 
dNTPs, 10 mM dithiothreitol, 40 units of RNAse inhibitors, 10 pM reverse 
primer, 200U Moloney Murine Leukemia Virus reverse transcriptase. 3 pg 
RNA were heated in 7pi of water at 65 °C for 15’ and were added to the 
buffer and incubated at 37 °C for 1 h. The reaction was stopped by 10 min on 
ice. Ipl of the reaction mixture was used for PCR amplification. PCR was 
carried out in a 50 pi reaction mixture containing 1 mM Tris-HCl pH 8.3, 50 
mM KCl, 1.5 mM MgCl2, 0.2mM dNTPs, 50 picomoles o f each primer, lU  
of PFU polymerase. The reaction proceeded according to a touch down 
protocol: dénaturation of 1 ’ at 94 °C; 30 cycles of 94°C for 45” , 62 ° -60 °- 
58 °C for 45” , 72 °C for 8 ’; a final extension of 72 °C for 5’. The two 
primers used were the sense primer PB4F3 (5’- 
TTCGATCAGCTAGACCTCCC-3’) and the antisense primer oligoB. The 
amplified PCR products were analyzed on a 1% agarose gel stained with 
ethidium bromide. The 5’ terminal fragment obtained from RT-PCR was
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cloned into the EcoRV site of a pBluescript SK plasmid. The resulting 
plasmid was named 5’ SK p4.
Construction of Mammalian Expression Vectors
The mammalian expression vectors for PLC P4a and PLC P4c were 
constructed by inserting the Bstul-Hindlll fragment of 5’SK P4, the Bstul- 
Sphl fragment of 3 ’ SK p4a and 3 ’ SK P4c respectively, into the Hindlll- 
Sphl site of pcDNAI. All DNA sequences were verified by sequencing 
(fluorescent dye terminator method and capillary electrophoresis, 3700 
Perkin-Elmer).
ANALYSIS OF PROTEIN EXPRESSION
Analysis of the expression of G in Ltk clones
Ltk" clones coltured in 10 mm dishes w ere detached by 0.5 mM 
PBS/EDTA and centrifuged. The pellet was frozen at -80 °C for at least 3 hr 
and then homogenized with a buffer (5 mM Tris-HCl pH 7.5, 1.5 mM MgCb, 
1 mM EGTA, 1 mM ATP, 1 mM pmercaptoethanol) containing 3 mM 
benzamidine, 1 mM phenylmethylsulphonylfluoride, 2 pg/ml Soy bean
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Tiypsin inhibitor, 2.5 pg/ml chymostatin, 2.5 pg/ml leupeptin, 2.5 pg/ml 
antipain and 2.5 pg/ml pepstatin. Membranes were separated by 
centrifugation at 100000 x g at 4° for 60’ in a Beckman TL-lOOs 
ultracentrifuge, resuspended in a buffer containing 20 mM Tris-HCl pH 8 , 2 
mM MgC12, 1 mM EDTA, 0.007% Pmercaptoethanol, 10% glycerol and 
stored at -20  °C. Proteins were measured by BCA (Bicinchoninic 
Acid)(Protein Assay Reagent, Pierce). A volume corresponding to 100 pg of 
proteins was drawn from each sample, mixed (30 : 21) with solubilization 
mix (4 % SDS, 0.8 M saccharose, 8 % Pmercaptoethanol, 0.008% 
bromophenol blue, 48 mM Tris pH6 .8 ), boiled for 5’, centrifuged briefly and 
fractionated by 10% polyacrylamide gel. Electrophoretic migration proceeded 
at 200 Volts for 5-6 h in buffer containing 50 mM Tris, 384 mM Glycine, 
0.1% SDS. The proteins were then electroblotted onto a nitrocellulose 
membrane (Schleicher and Schuell) at 4 °C overnight at 250 mA in 25 mM 
Tris, 192 mM glycine and 20% methanol. The membrane was preincubated 
for Ihr at room temperature in Blotto (50 mM Tris pH7.4, 150 mM NaCl, 
0.01 % Na-azide, 0.05 % Tween 20, 5 % non fat dry milk). A rabbit 
polyclonal antibody, raised by our laboratory against a peptide corresponding 
to the C-terminal ten aminoacids of G a^, was diluted 1:200 in Blotto and
incubated with the membrane at 4° overnight. The filter was then washed 
with Blotto two times for 15’ and three times for 5’. Binding o f the antibody 
was detected by incubating the filter with protein A (0,4 pCi/ml) diluted
144
in Blotto 1 h at room temperature. Then, the filter was washed with Blotto 
three times for 10 min and with TBS (50 mM Tris pH 7.4, 150 mM NaCl) six 
times for 3 min. Filter was exposed to autoradiographic films (Hyperfilm).
Analysis of the expression of G
Membrane from COS7 cells transfected in 10mm dishes were obtained as 
described previously for Ltk’clones. 30 pg of proteins mixed (30 : 21) with a 
solubilization mix (4 % SDS, 0.8 M saccharose, 8 % pmercaptoethanol, 
0.008 % bromophenol blue, 48 mM Tris pH6 .8 ) were boiled for 5’, 
centrifuged briefly and fractionated by 10  % polyacrylamide gel. 
Electrophoretic migration proceeded at 200 Volts for 5-6 hr in buffer 
containing 50 mM Tris, 384 mM glycine, 0.1% SDS. The proteins were then 
electroblotted onto a nitrocellulose membrane (Schleicher and Schuell) at 4 
°C overnight at 250 mA in 25 mM Tris, 192mM glycine and 20% methanol. 
The membrane was preincubated for Ihr at room temperature in Blotto. Anti- 
G aq  rabbit polyclonal antibodies (Santa Cruz) diluted in Blotto (0.2 pg/ml) 
were incubated with the membrane at 4° overnight. The filter was then 
washed with Blotto two times for 15’ and three times for 5’. Binding of the 
antibody was detected by incubating the filter with a 1 :1 0 ,0 0 0  dilution of 
horseradish peroxidase-conjugated anti-rabbit antibody in Blotto for Ihr at 
room temperature. The filter was washed with Blotto two times for 10’, and
three times for 5’ and with TBS one time for 5’. Immunolabeling was
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detected by ECL (enhanced chemioluminescence) system (Amersham) and 
visualized by exposure of the filter to Amersham Hyperfilm MP films.
Analysis of PLC p4a and PLC p4c expression
Membrane preparation, separation of proteins (200 pg) on 6  % 
polyacrylamide gels and immunoblotting were performed as described for 
detection of G aq. Rabbit polyclonal antibodies against PLC p4a (Santa 
Cruz) were used at a concentration of 0.2 pg/ml in Blotto. The rabbit 
polyclonal antibody was generated against the residues 
GSRDGPQTSNSSMKL of the C-terminal tail of PLC p4c and coupled to 
KLH (keyhole limpet hemocyanin) by Eurogentec; then it was affinity 
purified in our laboratory on Sepharose protein G columns (Pharmacia) or on 
peptide conjugated Tresyl Activated Agarose columns (Pierce) and diluted at 
2 pg/ml in Blotto.
Intracellular localization of the two PLC P4 variants
Tissues (~ 500mg) and cell lines were homogenized by pottering with 
homogenizing buffer (5 mM Tris-HCl pH 7.5, 1.5 mM MgCl2, 1 mM EGTA, 
1 mM ATP, 1 mM mercaptoethanol) containing 3 mM benzamidine, 1 mM 
phenylmethylsulphonylfluoride, 2 pg/ml S. Trypsin inhibitor and 2.5pg/ml
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chymostatin, 2.5 pg/ml leupeptin, 2.5 pg/ml antipain, 2.5 pg/ml pepstatin. 
The suspension was centrifuged at 100000 x g at 4 °C for 60 min in a 
Beckman TL-lOOs ultracentrifuge. The supernatant was separated from the 
pellet. This was resuspended in freezing buffer (20 mM Tris-HCl pH8 , 2 
mM MgCl2, 1 mM EDTA, 1 mM pmercaptoethanol, 10% glycerol). All 
samples were stored at -20  °C. Proteins were measured by BCA, separated 
by 6 % SDS-polyacrylamide gel electrophoresis and detected as described 
above.
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